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Abstract   
 
Biofabrication has been receiving a great deal of attention in tissue engineering and 
regenerative medicine either by manual or automated processes. Different automated 
biofabrication techniques have been used to produce cell-laden alginate hydrogel 
structures, especially bioprinting approaches. , These approaches have been limited to 
2D or simple 3D structures, however. In this thesis, a new extrusion-based bioprinting 
technique and a new simple, manual 3D biofabrication method are presented to culture 
cells in 3D. These methods do not rely on any complex fabrication methods. The 
bioprinting technique was developed to produce more complex alginate hydrogel 
structures. This was achieved by dividing the alginate hydrogel cross-linking process 
into 3 stages: primary calcium ion cross-linking for printability of the gel, secondary 
calcium cross-linking for rigidity of the alginate hydrogel immediately after printing 
and tertiary barium ion cross-linking for the long-term stability of the alginate hydrogel 
in the culture medium. Simple 3D structures including tubes were first printed to ensure 
the feasibility of the bioprinting technique. Complex 3D structures, such as branched 
vascular structures, were subsequently printed successfully. The static stiffness of the 
alginate hydrogel after printing was 20.18 ± 1.62 kPa which was rigid enough to sustain 
the integrity of the complex 3D alginate hydrogel structure during the printing. The 
addition of 60 mM barium chloride was found to significantly extend the stability of the 
cross-linked alginate hydrogel from 3 days to beyond 11 days without compromising 
the cellular viability.  The results based on cell bioprinting suggested that the viability 
of U87-MG cells was 92.94 ± 0.91 % immediately after bioprinting. Cell viability was 
maintained above 88 ± 4.3 % in the alginate hydrogel over a period of 11 days. 
 
On the other hand, the manual biofabrication approach developed in this thesis enabled 
the fabrication of scalable 3D cell-laden hydrogel structures easily, without complex 
machinery. The technique could be carried out using only apparatus available in a 
typical cell biology laboratory. The fabrication method would involve micro coating 
cell-laden hydrogels covering the surface of a metal bar by dipping into cross-linking 
reagent CaCl2 or BaCl2, to form hollow tubular structures. This method could be used to 
form single- or multi-layered tubular structures. This fabrication method has 
incorporated the use alginate hydrogel as the primary biomaterial and secondary 
biomaterial could be added depending on the desired application. The feasibility of this 
method has been demonstrated by showing  the cell survival rate and normal 
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responsiveness of cells within these tubular structures using mouse dermal embryonic 
fibroblast cells and human embryonic kidney 293 cells containing a tetracycline 
responsive red fluorescence protein (tHEK cells). By adjusting the fabrication protocol, 
complex hollow alginate hydrogel structures could be generated.  
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Chapter 1- Introduction & Literature Review 
1.1   Introduction   
Tissue engineering is rapidly developing biomedical field, which is defined as "an 
interdisciplinary field that applies the principles of engineering and life sciences toward 
the development of biological substitutes that restore, maintain, or improve tissue 
function or a whole organ” [1]. The field of tissue engineering was once considered as a 
subfield of biomaterials. But as the importance of this field became better understood 
and recognised, it is now considered to be an individual field on its own. 
Biofabrication as an emerging field that focuses on the use of biological cells, biological 
matters and biomaterials in order to produce biological systems. The combination of 
biofabrication and tissue engineering bring out the field of bioprinting and bioassembly. 
These involve either direct spatial arrangements of cells and biomaterials or automated 
process of cell assembly containing building blocks [2]. 
3D printing is recognised as Solid Freeform Fabrication (SFF), Additive Manufacturing 
(AM) and Rapid Prototyping (RP). A common application in the engineering world and 
various industries is to create a new prototype before releasing the original product. The 
prototype would be useful in order to make further improvements to the product.  3D 
printing could also be used directly for developing final products. 3D printing is a layer 
by layer fabrication process where the layers are laid on top of each other until a 3D 
structure is formed. The resolution of the part is based on two aspects. One is vertical 
resolution (Z resolution) which is the smallest achievable layer thickness. Another is 
horizontal resolution which is the smallest feature size that can be made through the XY 
plane. The 3D printing process can be performed by means of different technologies. 
3D printing technologies used in bioprinting field could be classified as follows: Inkjet 
based, valve based, extrusion based and laser based bioprinting [3]. 
Foundation studies of tissue engineering (TE) include the investigation of cell and tissue 
coalescence phenomena [4, 5], tissue affinity [6], cell adhesion [7] and the fluidity of 
embryonic tissue [8]. These fundamentals are necessary and essential to enable the 
process of tissue regeneration for tissues such as liver tissue [8], skin tissue [9], nerve 
[10] or any other tissues. Based on these fundamentals, cell aggregation and blood 
vessels can be assembled without use of synthetic polymers [11] using engineered 
  
 2   
 
spheroids [12]. A better understanding of these fundamentals is therefore needed to 
enable further development and progress in tissue engineering.  
The main goal of tissue engineering is the fabrication of synthetic tissue and organs to 
replace or repair damaged tissue or organ. The main motivation for this is the current 
crisis of organ shortage for medical transplantation. It was reported in 2012 that in the 
USA only 26,246 transplantations were performed, while 112,905 patients were still on 
the waiting list for organs [13]. This means more than 75% of patients were not given 
their treatment due to organ shortage. A report from National Health Service (NHS) 
from the United Kingdom in 2011/2012 states that only 3960 organ transplants were 
performed while 3676 other registered patients were on the waiting list [14].  To make 
the problem worse, transplantations are not always successful due to organ rejection or 
infection. These numbers do not reflect the situation less affluent countries where it 
could be much worse.   
 
Conventional scaffold-based fabrication technologies such as phase separation [15, 16], 
melt moulding [17, 18], fibre networking [19, 20], gas foaming [21-24], freeze drying 
[25, 26] and particle leaching [27-29] have been used for tissue regeneration and tumour 
models. However, the conventional scaffold-based approaches do not provide full 
control over the inner and outer geometry of the structure. This results in a 
heterogeneous structure with varying permeability and porosity due to the lack of 
control over the mechanical properties of the scaffold. Rapid Prototyping (RP) 
technologies, a more design-dependent method, could possibly overcome the control 
over mechanical properties, porosity and permeability of the scaffolds.   
 
In recent years, organ printing has emerged as a new area in tissue engineering to tackle 
some of the problems with organ fabrication.   Organ printing differs from conventional 
tissue engineering, which is mainly based on manual and labour-intensive methods of 
fabricating scaffold or tissue. 
Organ printing makes use of automated Solid Freeform Fabrication (SFF) technology 
(e.g. 3-dimensional fabrication) where cells and scaffold materials are deposited layer 
by layer until a 3D structure is formed. The recent progress based on bioprinting using 
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different RP technologies will be discussed in detail in the literature review later in this 
chapter.  
The literature review of this thesis will cover 3D printing, 3D bioprinting and some of 
the hydrogel materials used for TE.  A background based on different 3D printing 
technologies will be briefly described in this chapter. 3D bioprinting techniques and the 
use of different bio-inks for live cell printing into programmable patterns will be 
discussed. Each 3D bioprinting technique including their advantages and disadvantages 
will be described in detail. Finally, the conclusions will cover the outcome of the 
literature review and breakdown of each chapter for completion of this thesis. 
 
1.2    Inkjet based printing 
Inkjet based printing is used to assist tissue engineering. These are normal printers that 
are available off–the-shelf. The first ever commercially available Inkjet printer was 
introduced by Siemens in 1951 as a medical strip chart recorder [30]. Inkjet printers 
work based on two different mechanisms: drop-on-demand (DOD), as shown in Figure 
1.1, and continuous ejection mechanism, shown in figure 1.2. In drop-on-demand 
systems, electrical signals are used to control the ejection of an individual droplet. In 
continuous-drop systems, ink emerges continuously from a nozzle under pressure.  The 
jet then breaks up into a train of droplets, the direction of which is controlled by 
electrical signals [31]. Ejection of the droplets is caused by the pressure pulses created 
by thermal, piezoelectric or acoustic actuators. Both mechanisms have the capability to 
be operated with droplets ranging from 15 to several hundred microns [32]. Inkjet 
printing technology in the bioprinting field was first developed by Wilson and Boland in 
2003 at the Bioengineering Department in Clemson University USA. Wilson and 
Boland’s method was designed to dispense protein and viable cell solutions such as 
bovine aortal endothelial cells and smooth muscle cell line. Viability assays indicated 
roughly 75% of cells were viable after this bioprinting process [33]. Cell viability is 
usually defined by the number of live cells over the total number of cells. 
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Figure 1.1
__   
Inkjet printing by Drop-On-Demand mechanism [34] 
 
 
Figure 1.2 
__ 
Inkjet printing by continues ejection mechanism [34] 
 
The same team in Clemson University have applied thermal inkjet printing to fabricate 
microvasculature. The concept is to remove the ink from the cartridges, sterilise them 
and replace the ink with endothelial cells and thrombin as its bio-ink. A fibrinogen 
substrate is used as the bio-paper and where the cells in the bio-ink are deposited, a 
fibrin channel will form on the substrate as shown in Figure 1.3 [35]. Fibrin is 
polymerized using fibrinogen and thrombin solutions [36] and plays a key role for 
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natural wound healing. Fibrin could be taken from the patient’s own blood [37] and it 
has been widely used as a scaffold material for tissue engineering such as chondrocytes 
[38] skeletal muscle cells [39] and smooth muscle cells [40]. 
 
Figure 1.3 
__
 Schematic drawing for simultaneous dispositions of HMVEC and fibrin channels scaffolds 
using inkjet printing [35]. 
 
Another research group from Wake Forest Institute for Regenerative Medicine in the 
USA has used thermal inkjet printing to construct a complex heterogeneous tissue 
containing multiple cell types. Cartridges were emptied and each of them was filled 
with different cells mixed with calcium chloride. The cell types used were canine 
smooth muscle cells (dSMCs), bovine aortic endothelial cells (bECs) and human 
amniotic fluid-derived stem cells (hAFSCs). Each cell type was printed into a pie-
shaped structure in different locations (Figure 1.4 and Figure 1.5) and was delivered 
into a sodium alginate-collagen composite. The reaction between the calcium chloride 
and sodium alginate-collagen resulted in the rapid formation of the gel. Since the 
structure had a thickness, the inkjet printer was modified by adding a vertical axis 
motion. The heterogeneous construction was evaluated in vivo and in vitro where the 
cells remained viable with normal proliferation rates, phenotypic expression and 
physiological function. The viability of the printed constructs was evaluated at day 1, 4 
and 7 after culturing [41]. 
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Figure 1.4 
__ Light (A) and fluorescence (B) microscopic top views of a complete 3D multi-cell “pie” 
construct before implantation. The cells that appear green are bECs labelled with PKH 26 dyes; the cells 
that appear blue are hAFSCs tagged with CMHC dyes; the cells that appear red are dSMCs labelled with 
PKH 67 dyes. Different cells were located onto their predetermined locations after printing [41]. 
 
 
Figure 1.5  
__ 
Schematic drawing of applying inkjet printing to fabricate multi-cell heterogeneous tissue 
constructs[41]. 
 
A research group from the University of Toyama in Japan developed a piezoelectric 
inkjet printer to bioprint alginate hydrogel tubular structures.  The custom-made Inkjet 
3D bioprinter used a piezoelectric type inkjet head where sodium alginate solutions at 
0.8 % weight to volume ratio (w/v) were inkjet-printed into a cross-linking reagent of 
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2% (w/v) CaCl2 bath prepared in hyaluronan or polyvinyl alcohol (PVA) at 0.5 % or 15 
% respectively. The cross-linked alginate micro beads generated by this approach 
ranged from 26 µm to 38 µm in diameter. In order to produce tubular structures, the 
print head would move in a circular motion to print a 2D ring structure in the CaCl2 
bath. This process would be repeated several times to generate alginate hydrogel tubular 
structures as shown in Figure 1.6. [42] 
 
 
Figure 1.6 
__
 A hollow alginate hydrogel tubular structure printed by Inkjet head using pizo type inkjet 
head [42]. 
Despite being capable of printing viable cells with suitable resolution, inkjet bioprinting 
technologies are not sufficiently well adopted to build up 3D cell-laden structures. This 
is due to the inability of inkjet printing to print viscous material that would result in less 
favourable mechanical properties of the cell-laden structures [43]. In general alginate 
hydrogel at concentrations of less than 2% (w/v) is recommended for use in inkjet-based 
bioprinting [44-46]. 
 
1.3   Laser-based bioprinting  
Laser-based printing was first commercially available in 1976 when IBM created a 
nozzle-free dispensing system called IBM 300. [47] The first ever laser based printer to 
print 2D cell patterns was developed in 1999 by Odde and Renn [48]. 
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The laser-based technologies that are mainly used in bioprinting field are laser-induced 
forward transfer (LIFT) and matrix-assisted pulsed laser evaporation direct writing 
(MAPLE DW). These techniques (shown in Figure 1.7) work in similar manners where 
a laser transparent ribbon is placed underneath a layer glass or quartz. A cell solution 
suspended in a culture medium with either glycerol or hydrogels is coated onto the 
bottom of the ribbon. Cell solutions usually have a concentration of around 1×10
8
 
cells/mL depending upon the cell type, where the coated solution on the ribbon ranges 
from 10 µm to 100 µm thick [49, 50]. The receiving substrate is usually placed from a 
distance of 30 μm to 1000 µm from the ribbon [51]. To dispense the cells a laser pulse 
is directed at the ribbon, causing the formation of a bubble. The shock waves caused by 
the formation of the bubble eventually force the cells to be dispensed towards the 
substrate. Laser-based printing is the only nozzle-free dispensing approach. It has a 
higher dispensing resolution compared to the other bioprinting technologies, making it a 
superior bioprinting technology to print single cells. For example, mammalian cells 
could be printed onto a hydrogel substrate as individual cells [52], which could allow 
bioprinting of the smallest parts of certain human body organs or tissues. Laser fluence 
and the biomaterial during printing will have a direct effect on cell viability however. A 
study from Chrisey and his co-workers from Clemson University used the LIFT 
technique to bioprint NIH 3T3 fibroblast cells suspended in 1% (w/v) alginate solution 
in the medium and CaCl2 cross-linking reagent for 2 minutes and 10 minutes [53].  The 
study indicated that higher laser fluence resulted in lower cell viability. This is due to 
shear stresses/strains developed during jet/droplet formation [54] and landing [55, 56].  
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Figure 1.7 
__    
Working principle of laser-induced forward transfer (LIFT), and matrix-assisted pulsed 
laser evaporation direct writing (MAPLE DW) [57] 
Laser-based bioprinting is a capable of printing higher viscosity biomaterials compared 
with inkjet-based bioprinting. This makes it a superior technology for printing structures 
with better mechanical properties.  For instance, the department of biomedical 
engineering at Renseeler Polytechnic Institute has used 8% (w/v) alginate as a popular 
hydrogel material to create cell-encapsulated microbeads [58, 59].  Human breast cancer 
cells (ATCC, Manassas, VA) suspended in a 2% alginate and 10% gelatine composition 
were dispensed using LDW into a 2% (w/v) calcium chloride solution to cross-link the 
beads as shown in Figure 1.8. Cells encapsulated with the microbeads had a viability of 
89.6%, decreasing to 84.3% after five days of culture. This makes this technology 
suitable for drug discovery applications [59]. 
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Figure 1.8 
__ 
Schematic drawing of laser-based bioprinting of encapsulated human breast cancer cells in 
alginate-gelatine microbeads cross-linked with 2% CaCl2 for 10 minutes [60]. 
 
With the ability to print more viscous materials by laser-based printing it is possible to 
print more rigid structures, generating structures with greater complexity compared to 
printing in 2D or 3D with limited aspect ratio. The team at Renseeler Polytechnic 
Institute has used laser-based printing to produce alginate tubular structures with 2%, 
4%, 6% and 8% alginate hydrogel. In this approach, the ribbon containing the alginate 
hydrogel is placed 1 mm above the CaCl2 solution with 2% concentration. The alginate 
beads are deposited through the laser pulse into the moving platform, which is 
submerged in the CaCl2 solution to cross-link the alginate hydrogel. [61] This process 
repeats several times while the moving platform is further submerged into the cross-
linking bath until the tube structures are formed. The study showed that tubular 
structures printed with higher alginate concentrations under the same laser power of 
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1437 ± 28 mJ cm
–2   
created rings with better uniformity and printing resolution. In their 
recent studies (figure 1.9), the team at Renseeler Polytechnic Institute used a lower 
alginate hydrogel concentration of 2% rather than 8% as this gave better diffusion of 
oxygen, nutrient, and wastes [62]. Mouse fibroblast cells were suspended in 2% alginate 
bio-ink and printed into a 2% CaCl2 solution with cell culture medium at 1:1 (v/v) [63]. 
However, the cell viability was around 60% immediately after printing. This indicates 
that this approach is not still suitable for printing highly viable cells in 2% alginate, 
which is a mid-range viscosity bio-ink. 
 
Figure 1.9 
__ 
Schematic drawing of the laser based printing setup to printing hydrogel tabulator 
structures [60]. 
 
1.4    Valve based printing 
Valve based printing is a relatively new technique emerging in the last decade in which 
the bioprinting world has been under development. Valve-based printing works in a 
similar manner to inkjet-based printing, where droplets are dispensed from a reservoir 
through a nozzle using static air pressure. The bio-ink is dispensed once the voltage-
controlled valve is activated [64, 65]. The droplet size is determined by the nozzle 
diameter, air pressure and valve opening time [66]. 
Valve based bioprinting was first developed by Demirci and his co-workers. The cell 
types to verify the feasibility of this novel technology were mammalian cells: AML-12 
hepatocytes, NIH-3T3 fibroblasts, HL-1 cardiomyocytes, mouse embryonic stem cells 
and RAJI cells. All printed cell types had a viability over 89%, indicating this novel 
technology is very gentle on cells [65]. 
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In 2013 Shu and his co-workers described a microvalve based printing method for 
bioprinting human embryonic stem cells to form cell aggregates.[67] This was the first 
time human embryonic stem cells were printed, opening up tremendous applications in 
stem cell studies in the future. The human embryonic stem cells (hES) cells were 
printed under various air pressures ranging from 4 PSI to 23 PSI. Cell viability was over 
70 % after 24 hrs of culture and over 80% after 72 hrs of culture after bioprinting for all 
the pressures.  
 
Figure 1.10 – Schematic of valve-based printing compatible to bioprint viable hES cells [66] 
 
The same techniques have also been used to bioprint a novel DNA hydrogel material 
with live cells in millilitre-range structures [68]. It is reported that pluripotent stem cells 
could be differentiated into hepatocyte-like cells for 3D mini-liver generation [69]. 
Similar to inkjet based printing, valve based printing is currently limited to printing 
highly viscous materials despite being very gentle on cells, especially embryonic stem 
cells. It is therefore difficult to generate larger 3D structures with a degree of 
complexity [69]. 
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1.5   Extrusion-based bioprinting  
Extrusion-based printing works in a different manner compared with the other printing 
methods explained in this chapter. Instead of ejecting droplets into a pre-designed 
format, materials are continuously deposited as filaments through a nozzle layer by 
layer until a 3D structure is constructed. Extrusion-based printing is derived from fused 
deposition modelling (FDM), which was developed in the 1980s by Scott Crump. The 
first commercially available FDM printer was created in 1990 by Stratasys [70].  FDM 
usually works by extruding plastic or metals via heat; softer materials such as ceramic 
are extruded by mechanical pressure.  
 
Extrusion-based systems in bioprinting all work in a similar manner, where hydrogel/ 
bio-inks are extruded via pressurised air, rotary screw or by a piston (as shown in Figure 
1.11). Extrusion-based systems using pressurised air can dispense a variety of materials 
such as pure liquids [71] pastes [72] and semi-molten polymers [73].  The main 
disadvantage of this approach is the inability to extrude highly viscous material due to 
the limitation of air pressure [74]. Piston-driven and screw-driven depositions allow the 
printing of more viscous materials, making these a more suitable approach for the 
printing of 3D structures with more onerous mechanical properties.   
 
Figure 1.11 
__ 
extrusion based printing with different mechanisms. (a) Extruded filaments via pressurised 
air, (b) rotary system and (a) mechanical piston. 
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Using higher viscosity materials will result in 3D structures with better mechanical 
properties. However, due to the higher shear stress and surface tension applied to the 
materials/bio-inks during their extrusion [75-79] there is a risk of damage to the plasma 
membrane, reducing cell viability [80, 81]. For this reason there are various research 
groups developing new and novel approaches based on extrusion-based 3D printing to 
construct 3D cell-laden structures. 
 
Extrusion based printing has been used to successfully demonstrate the ability to print 
scaffolds for bone generation in the field of hard tissue engineering [82, 83]. The 
majority of recent works on soft tissue printing are limited to 2D or very simple 3D 
structures with limited aspect ratio, however.  
Sun and his co-workers developed a new extrusion-based technology to bioprint Hela 
cells to create a 3D cancer model in-vitro to evaluate cancer studies in 2D [84, 85]. The 
bio-ink used for this method was a composition of 10% gelatine, 1% sodium alginate 
and 2% fibrinogen. The composition was then loaded into a syringe at 25 
o
C and 
extruded at 10
 o
C. A lower temperature was used to keep the gelatine in the gel state. 
3% CaCl2 solution was used to cross-link the alginate and the alginate was then 
submerged into a 20 U mL
−1
 thrombin for 15 minutes to cross-link the fibrinogen. This 
technology, despite being able to support tumour growth within the printed bio-ink as 
well as human embryonic stem cells [86], is not able to print 3D structures taller than 3 
mm [87].  
 
 
  
 15   
 
 
 
Figure 1.12 
__   
Schematic drawing of 3d printing setup to bioprint suspended Hela cells, HES cells and 
human corneal epithelial cells in alginate alginate/gelatin composition [85]. 
A research group from Department of Dental Materials and Biomaterials Research at 
RWTH University Hospital developed a new technique to print 3D cell-laden hydrogel 
structures. The method incorporates the use of high density fluid to support the integrity 
of printed cell-laden hydrogel as shown in Figure 1.13 [88].  The bio-ink consisted of 
human mesenchymal stem cells (hMSC) at a concentration of 1 × 10
7
 cells/mL 
suspended in 1.5% (w/v) agarose. The cell-laden hydrogel is deposited layer by layer to 
form a 3D structure in a fluorocarbon reservoir, a high density hydrophobic fluid to 
support the cell-laden hydrogel. The printing technique is gentle on cells while keeping 
the cell viability over 90% after both 24 hrs and 21 days of culture. Despite the method 
being capable of printing highly viable cells into a 3D structure, there is a limitation on 
the complexity of the structures: they are limited to simple tube structures as shown in 
Figure 1.14. 
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Figure 1.13 
__ 
Schematic drawing of 3D bioprinting cell-laden hydrogel mechanically supported by high-
density fluorocarbon liquid [88]. 
 
 
Figure 1.14 
__   
3D printed cell-laden hydrogel ring construct submerged in fluorocarbon. (a) Top and (b) 
side view of the construct [88].  
Several research groups have incorporated the use of printed support material to create 
3D cell-laden hydrogel structures. For example, Butcher and co-workers [89] from 
Cornell University developed a photo-curable hydrogel to bioprint 3D structures with 
the use of support material consisting of very viscous alginate/gelatine solution. The 
bio-ink used was 20% Poly (ethylene glycol)-diacrylate (PEG-DA), 12.5% alginate with 
1% photoinitiator.  The bio-ink was printed by Fab@Home using a 0.85 mm diameter 
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nozzle. Once a layer of bio-ink is printed the support material is printed correspondingly 
(Figure 1.15). This is then exposed to Ultraviolet (UV) light for 30-60 seconds to cross-
link the bio-ink. The process is repeated as many times as desired until the 3D structure 
is formed. The technique is capable of bioprinting 3D structures with great complexity; 
however the exposure of cells to potentially harmful UV radiation could damage the 
cells. Furthermore, the bio-ink used is very concentrated, which would lead to low 
permeability within the structure, affecting cell proliferation. Another disadvantage of 
this method is the use of a nozzle with a large diameter, which limits the X-Y 
resolution. The use of a smaller nozzle would cause higher shear stress, eventually 
damaging the cells during the bioprinting process. Similar technologies have been used 
to generate a human ear structure using biodegradable PCL structure, printing a 
removable sacrificial layer [90]. Due to the high temperature needed to deposit PCL, the 
technique could potentially be harmful to many delicate cell types. 
 
Figure 1.15
__  
 3D bioprinting of human heart valve structure using a novel approach by incorporating 
photocurable bio-inks with support materials [89].  
 
1.6 Hydrogels 
Hydrogels are the basis of 3D bioprinting in tissue engineering due to their many unique 
features, such as the creation of a hydrated and mechanically supportive extracellular 
matrix (ECM) to ensure cell encapsulation. Biocompatibility of each hydrogel is mainly 
determined by its hydrophilicity [3]. Due to their high biocompatibility hydrogels are 
commonly used in the bioprinting field [91]. Hydrogels can generally mimic the 3D 
environment similar to the physiological condition.  
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Hydrogels are divided into two categories. One is naturally-derived hydrogels such as 
fibrin, chitosan, collagen and alginate [92-94]. The other category is synthetically-
derived hydrogels such as polyethylene glycol and pluronics [95-97]. Naturally-derived 
hydrogels are favoured over the synthetically-derived hydrogels in the tissue 
engineering and bioprinting field due to their higher biocompatibility, as synthetic 
hydrogels are not as biofunctional as natural hydrogels. 
For bioprinting, hydrogels are used as bio-ink to encapsulate cells and provide the initial 
cell delivery platform. Several cell types, especially stem cells, can be encapsulated 
within these hydrogels and subsequently printed [98].   
Although many hydrogels have been used for bioprinting, alginate hydrogel is chosen in 
this present study to be used for the bioprinting process due to its high biocompatibility 
and wide range tunability of the hydrogel especially when used with stem cells [98]. 
Mechanically this hydrogel can be enhanced by increasing its concentration or through 
ionic cross-linking with CaCl2 or BaCl2, which makes it suitable for printing 3D 
structures with better mechanical properties and integrity. Another advantage of this 
hydrogel is the controllability over its degradation, which provides cells encapsulated 
within the hydrogel with enough time to grow and proliferate. Another reason for 
choosing alginate hydrogel over other hydrogels and biomaterials is its fast gelation, 
which makes it one of the most printable hydrogels. 
 
1.7 Conclusion 
Of the main four 3D bioprinting techniques, Inkjet-based and valve-based bioprinting 
techniques have a high throughput and high cell viability. They are limited to printing 
simple 2D and 3D structures with a limited aspect ratio, however, which will certainly 
lack mechanical stiffness due to the limitation in printing concentrated bio-inks. 
Extrusion- and laser-based technologies are capable of printing bio-inks using medium 
to high viscosity materials, which creates a suitable bioprinting platform for printing 3D 
structures with better mechanical properties as previously demonstrated. The use of bio-
inks with higher viscosity could damage the cells during the printing process due to 
high shear stress, however. Alterations in either the bio-inks or the 3D printing process 
are therefore essential. In this thesis, extrusion-based printing was chosen over laser-
based printing. This was due to the ability to print medium to high viscosity 
biomaterials using this method.  
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Research carried out so far involved the creation of simple structures using extrusion-
based bioprinting. This study investigates the feasibility of enhancing the biomechanical 
properties before, during and after bioprinting, with a view to enabling the creation of a 
complex cell-laden 3D structure. Manual approaches for fabricating cell-laden tubular 
structures and, potentially, complex 3D structures are also considered. The availability 
of an effective manual approach would allow more widespread fabrication of 3D 
structures without the need for complex and expensive machinery and the associated 
operational resources. 
Following the introduction and literature review on 3D printing, 3D bioprinting and 
hydrogels in this chapter, the remaining chapters are as follows: 
Chapter 2 describes the experimental techniques and methods used in the thesis.   
Chapter 3 explains the development of the novel 3D bioprinting platform to bioprint 
complex 3D structures through a three step cross-linking process using a tuneable 
alginate hydrogel.   
Chapter 4 further investigates the novel 3D bioprinting platform by focusing on cell 
viability for short-term cell culture (immediately after bioprinting) using different 
viscous alginate hydrogel. The most suitable hydrogel concentration is used to assess 
the long-term cell viability within the alginate hydrogel.  
Chapter 5 presents a simple approach for the 3D fabrication of single and multi-layered 
alginate hydrogel tubular structures.  
Chapter 6 reports on the feasibility of a dip coating approach, considering factors such 
as cell viability, cell function, cell attachment and incorporation of other biomaterials 
into alginate hydrogel tubular structures.  
Chapter 7 summarises the work output from the thesis and possible recommendations 
for future studies.   
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Chapter 2 - Experimental techniques 
2.1   Introduction 
This chapter summarises experimental techniques and other methodologies to assist the 
research towards the completion of the thesis. The methods and experiments used to 
assemble and modify a specialised bioprinter are presented. This is a novel technique to 
bio-print complex cell-laden alginate hydrogel structures. The main bioprinting 
technique used to print complex hydrogel structures is discussed in detail in chapter 3.  
Other experimental techniques in order to measure hydrogel viscosity and mechanical 
properties are discussed in this chapter. Different imaging instruments used for 2D and 
3D live cell imaging are described along with other imaging tools. CAD, image 
processing and printing programs that were used to assist the project are discussed. The 
chapter is completed with a review of other techniques such as plasma treatment, cell 
culture, and nanofibre fabrication.  
 
2.2    Solid Edge V20 and CorelDRAW  
Solid Edge V20, a piece of design software, played a crucial role throughout the 
research carried out within this thesis. It was primarily used to create models for the 3D 
bioprinting of alginate and cell-laden alginate hydrogel structures.  Designs for the 
creation of complex 3D alginate hydrogel structures through dip-coating approach were 
created using Solid Edge V20. CorelDRAW, compatible with the CO2 laser, was used 
to create X-Y cutting patterns for the laser cutter. The 2D parts were initially designed 
through Solid Edge and converted to xdf files, which are compatible with CorelDRAW. 
Solid Edge was an effective tool for creating designs of any broken bioprinter parts. 
These were then fabricated for bioprinter maintenance purposes.   
  
2.3   Fab@Home 3 printing procedure   
A Fab@Home 3 3D printer was purchased from Seraph Robotics for 3D bioprinting of 
hydrogels and assembled in accordance with the manufacturer’s protocol. The 
Fab@Home consists of 3 main components: the transmission, chassis and the 
electronics. The chassis, which contains the electronics and transmission is made of 6 
mm cast acrylic or PMMA. The transmission was used to guide the printhead in the X-
Y-Z plane. The electronics consist of a Snap hub that controls five servo motors. Three 
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of the servo motors control the X-Y-Z motion of the print head and two are used for the 
dual extrusion print head for material extrusion purposes. This model of printer is 
widely used in the bioprinting field. The printing procedure is simple and 
straightforward as shown in Figure 2.1. 
Solid Edge V20 CAD software was used to create designs that were converted to 
Stereolithography (STL) files. These are compatible with the Fab@Home 3 software 
called Seraph Studio. Seraph Studio software enabled the positioning of the design on 
the printing platform as desired. The design was loaded with the desired material and 
then Seraph Studio generated an xdfl file which would create the printing path, printing 
speed, path width, path height, and extrusion rate. These parameters were initially 
calibrated for printing alginate hydrogel at certain concentrations. Once the xdfl file was 
created, it was opened by the Seraph Print software, which was connected to the 3D 
printer through a personal computer (PC). The Seraph Print software can adjust the print 
head to the desired position and start, run and end the printing process. 
The 3D printer has a dual extrusion print head with a 10 mL reservoir volume. The 
positioning accuracy was approximately 100 µm along the XYZ plane with the 
maximum travel speed of 80 mm/s. The typical travel speed for printing the majority of 
the materials for this printer was 10 mm/s, however. The printer build platform was 230 
mm × 128 mm × 200 mm in the XYZ plane.  This printer model could be modified in 
different ways; for example a heated build tray and a UV light tool could be added to 
provide the possibility of 3D printing a wider range of materials.   
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Figure 2.1 
__ 
assembled Fab@Home 3 3D printer 
 
Figure 2.2 
__ 
Fab@Home 3D printing procedure 
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Figure 2.3 
__
 Seraph studio loaded with STL file to generate xdfl file for print path generation for3D 
printing of alginate or cell-laden alginate hydrogel structures. 
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2.4   CO2 laser system  
The Trotec Speedy 300 CO2 laser system is an engraving machine with a working area 
of 726 mm × 432 mm. It was used to laser cut PMMA into parts to modify the 
Fab@home 3 3D printer or used in order to fabricate parts that needed to be replaced in 
the 3D printer for maintenance purposes. It was also used to laser cut paper substrates 
and hollow out PMMA substrates for 3D bioprinting of hydrogel. The laser power 
ranges from 10-50 Watts. 
 
Figure 2.4 
__
 (a) Trotec Speedy 300 CO2 laser system setup. (b) The working area of the laser and (c) the 
laser cutter head. (d) Control panel of the Laser system to adjust the platform Z level and the laser cutter 
head position in X-Y. 
 
2.5   Ultrasonic bath  
An ultrasonic bath (RK 102 H, BANDELIN SONOREX, Germany) was used to prepare 
alginate hydrogel, alginate-collagen and alginate-gelatine solution to ease the mixing 
process. Any nozzles blocked during 3D printing or 3D bioprinting were unblocked by 
the ultrasonic bath by breaking down the particles causing the blockage inside the 
printing nozzles.  
 
2.6 Plasma treatment 
A plasma Machine (diener electronic, Zepto version B, Germany) was used to make 
PMMA surfaces hydrophilic to ensure the attachment of alginate hydrogels on PMMA 
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surfaces for printing simple 2D alginate hydrogel structures. Glass slides or Petri dishes 
were also treated by the plasma machine to make their surfaces more hydrophilic, 
ensuring the attachment of bioprinted cell-laden alginate hydrogels. The treated petri 
dishes were also used for spin-coating of the alginate.  
2.7   MakerBot 3D printer for part fabrications 
MakerBot Replicator 2X is capable of printing ABS and PLA and was used to 3D print 
parts needed to modify the Fab@Home 3 for bioprinting alginate and cell-laden alginate 
hydrogel structures.  This 3D printer was used to 3D print solid plastic organ-like 
structures such as solid stomach and solid branched structures. These were used to to 
fabricate the silicon moulds needed for the creation of complex 3D hydrogel structures. 
Fabrication of complex alginate hydrogel structures by the dip-coating approach is 
further discussed in Chapter 5, section 5.9. 
 
Figure 2.5 
__
 MakerBot Replicator 2X 3D printer used to fabricate solid plastic human body parts and 
parts for modification of Fab@Home 3D printer. 
 
2.8   Mechanical testing 
A Mach-1™ mechanical indenter (Biomomentum, Canada) was used to measure the 
mechanical properties of the bioprinted alginate hydrogel structures treated by different 
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cross-linking conditions. The settings and configurations used for testing the alginate 
hydrogel mechanical properties are covered in chapter 4, section 4.11.  
 
Figure 2.6 
__   
Mach-1™ mechanical indenter used for hydrogel mechanical properties measurement  
 
2.9   Viscosity measurements  
A Bohlin Gemini rheometer was used to measure zero shear viscosity and dynamic 
viscosity of various concentrations of partially cross-linked alginate hydrogels in order 
to find the optimum viscosity conditions for 3D bioprinting cell-laden alginate hydrogel 
structures. Viscosity measurements were taken at room temperature as the bioprinting 
of the cell-laden alginate hydrogel was carried out at room temperature. CP4/40, a 
40mm diameter cone with an angle of 4°, was used to take the viscosity measurements. 
The hydrogel viscosity results are further discussed in chapter 3, section 3.6.
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Figure 2.7 
__
  The rheometer used to measure zero shear viscosity and dynamic viscosity of partially 
cross-linked alginate hydrogels  
2.10   Gelatine nanofibre fabrication to enhance cell attachment  
Nanofibres were fabricated in this research for enhancing the attachment of cells to the 
biomaterial. 10 g of gelatine powder (Gelatine from porcine skin, product code 
10011968154, Sigma-Aldrich UK) was mixed with 20 mL of de-ionised water. 40 mL 
of acetic acid was added to the water-gelatine solution and was gently stirred for 5 
minutes.  32 mL of ethyl acetate was added to the solution and stirred gently for 5 
another minutes. The final solution was then incubated for 12 hrs at 37°C as shown in 
Figure 2.8. 
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Figure 2.8
__
   The water-acid based gelatine solution incubation at 37 °C  for 12 hrs. 
 
Once incubated for 12 hours, 3 mL of the water-acid based gelatine solution was loaded 
into a 5 mL syringe and electrospun for 24 hrs at 0.06 ml/hr by 12.5 KV/8cm with a 
500 µm tip.  
 
Figure 2.9 
__
 Electrospinning of water-based gelatine solution setup
 
 
The fabricated nanofibrees then were removed from the aluminium foil tray and were 
ground using an electric grinder. The fabricated fibrenanofibres had diameters ranging 
from 50 nm to 250 nm .Once the nanofibres were ground, a 100- micrometre sieve was 
used to separate the beads that are smaller than 100 µm. 
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2.11   Scanning electron microscope 
A scanning electron microscope (SEM), a powerful imaging device capable of imaging 
structures at the nanoscale was used to capture images of the electrospun gelatine 
nanofibre to confirm the existence of nanofibres. Samples were first taken from 
electrospun gelatine nanofibres and gold sputter coated before SEM examination to 
make sure the electrons were directed at the sample for imaging. Samples were 
transferred to the sputter coating chamber and vacuumed. Once vacuumed, sputter 
coating was performed at 2.5 KV and 20 mA for 45 seconds, resulting in a few 
nanometre-thick gold layers on the samples. Sputter coated samples then were taken to 
SEM for imaging. Images were taken at 5 KV with magnifications of 3000, 5000, 
20000 and 50000. 
 
 
Figure 2.10 
__ 
Sputter coating chamber used to coat nano layers of gold on gelatine nanofibre samples. 
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Figure 2.11
__ 
Scanning electron microscope setup used for imaging gelatine nanofibre samples at 
different magnifications. 
2.12   2D cell imaging  
2.11.1   Nikon eclipse Ts100 2D imaging microscope 
One of the imaging instruments used in this research was the Nikon eclipse TS100. It 
was mainly used to count the number of U87-MG cells to estimate the overall number 
of cells used for bioprinting cell-laden alginate hydrogel structures as described in 
chapter 4. It was also used to image U87-MG and fibroblast cell attachment throughout 
the 4 days of culture of alginate-gelatine tubular structures fabricated by the dip-coating 
approach described in chapter 6.  Images of U87-MG cell-laden alginate hydrogel 
extruded manually through altered-diameter tips were captured by this 2D imaging 
device throughout the 4 days of culture as described in chapter 4. 
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Figure 2.12 
__
 Nikon eclipse Ts100 2D imaging microscope. 
 
2.11.2   Zeiss Axiovert Immunofluorescence 
A Zeiss Axiovert Immunofluorescence 2D imaging microscope was used to capture 
images of induced and non-induced tHEK cells within the tubular structures fabricated 
by the dip-coating approach through 6 days of culture as described in chapter 6. The 
instrument was also used to capture images of MDCK cell attachment on monolayer 
sheets of different biomaterial compositions, as well as capturing images of the tubular 
structures over 6 days of culture as described in chapter 6. Images of fibroblast cell 
attachment on different 2D monolayer biomaterial compositions were captured by this 
microscope as described in chapter 6. 
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Figure 2.13 
__ 
  Zeiss Axiovert Immunofluorescence 2D imaging microscope 
2.13   3D cell imaging  
2.12.1 Leica SP5 SMD 
Leica SP5 SMD confocal microscopy was used to capture confocal images of 
bioprinted U87-MG cell-laden alginate hydrogel structures throughout 11 days of 
culture to quantify the cell viability immediately after bioprinting and throughout the 11 
days. Confocal images of encapsulated U87-MG cells in different tubular structures and 
fabricated by various alginate compositions via the dip-coating approach were captured 
by this confocal imaging instrument to identify the attachment of U87-MG cells to the 
alginate compositions.   
 
Figure 2.14 
__   
Leica SP5 SMD confocal imaging microscope setup
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2.12.2   Nikon A1R FLIM confocal microscope 
A Nikon A1R FLIM confocal microscope was used to capture confocal images of 
mouse dermal fibroblast cells encapsulated within tubular structures fabricated by the 
dip-coating approach. The images were captured throughout 6 days of culture within the 
tubular structures to identify the cell viability. 
 
 
Figure 2.15 
__ 
Nikon A1R FLIM confocal microscope
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Chapter 3 - 3D bioprinting of complex alginate hydrogel structures 
3.1 Introduction 
In the past decade, three-dimensional (3D) bioprinting as an emerging new technology 
for tissue engineering has made significant progress towards the regeneration of 
transplantable tissues [1-3] and even organs such as human ear, bones, skins, and nose  
[4-7] for restoring or repairing damaged body tissues. Various biofabrication techniques 
including inkjet printing [8-12], bioextrusion [13-15], valvejet printing [16-19], laser 
based printing [20-24] and photopolymerization [25-26] have been developed for the 
3D printing of live cells and bioscaffold. Although the fabrication of clinically scaled 
hard tissues such as bones has already been successfully demonstrated [6], the 
bioprinted scaffolds for soft tissues has to date been limited to clinically small-scale 
structures with limited complexity.  
 
The key challenge has been the difficulty of striking a good balance between the 
conditions for printing highly viable cells and producing sufficiently a strong scaffold to 
support clinical scale cell-laden structures at the same time.  Take bioextrusion of 
hydrogels, for example, where small-diameter nozzles and highly viscous hydrogel 
materials were desirable for achieving a good printing resolution with sufficient 
mechanical rigidity for building 3D hydrogel structures.  But the higher extrusion forces 
needed to print these highly viscous materials from a small nozzle would lead to higher 
shear stresses and hence reduced cell viability during the printing process. To overcome 
this key challenge, different bioprinting approaches have been developed. Butcher and 
his co-workers [27] developed a novel ultraviolet (UV) bioextrusion printing technique 
for complex 3D structures. Living cells in a UV curable, low-viscosity PEG hydrogel 
solution were printed with in-situ UV radiation to solidify the printed hydrogel 
constructs layer by layer. As the hydrogel was cross-linked after the cells were extruded 
from the printing nozzle, this technique was able to significantly reduce the shear stress 
associated with printing high-viscosity hydrogels and produce sufficiently strong UV 
cross-linked structures for the regeneration of a clinical-scale human heart valve. The 
limitation of this approach, though, was the need for photosensitive hydrogel materials 
and the exposure of live cells to potentially harmful UV radiation and toxic photo-
initiators. 
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On the other hand, more rigid poly (ε-caprolactone) PCL as a biodegradable scaffold 
[28] or high dense fluid oil [29] was used to support soft cell-laden hydrogels. The use 
of such hybrid plastic and hydrogel scaffolds enables bioprinting of organ-size 
structures like a human ear. However, the need for high temperature printing and acid, 
producing degradation of PCL, might limit their application for tissue regeneration. 
Alternatively, lowering the temperature of hydrogels in printing enhanced mechanical 
rigidity before the gel was cross-linked, resulting in pure alginate constructs that have 
shown the ability to support tumour growth in 3D [30, 31].  
 
In this chapter, a new bioprinting technique using modified Fab@Home 3D printer for 
complex 3D alginate hydrogel structures is presented. The technique uses a three step 
cross-linking process to ensure the printability, rigidity, and stability of the gel that 
could be gentle to cells during the bioprinting process. Alginate hydrogels were chosen 
because of their biocompatibility and ability to form highly porous structures for cell 
regeneration. The degradation time of the alginate hydrogel is also investigated. Cell 
studies on live cell printing are described in the subsequent chapter. 
 
3.2 Hair gel 3D printing  
Hairgel (Sainsbury's Hair Gel Pot, Item Code: 6303600, Sainsbury’s, UK) was first used 
to mimic 3D printing of alginate hydrogel. The gel was selected due to its similar 
viscosity and low cost in large quantities. 2D and 3D structures were printed by 
Fab@Home 3 model. Path speed was set 6 mm/s and extrusion rate was set at 0.45 
mL/min. A nozzle with 514 µm tip diameter (OK International) was used to print the 
hairgel structures. Simple 2D rectangular and triangular shapes (Figure 3.1a and Figure 
3.1c), hollow square structure (Figure 3.1c), star shape (Figure 3.1d) and 2D lines 
(Figure 3.1e) were successfully printed. The best possible repeatable resolution, 
achieved with the 514 µm tip, was roughly 625 µm. 
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Figure 3.1 
__
 Simple hairgel 2D structures printed by Fab@Home 3D printer. (a, c) Simple 2D 
rectangular and triangular shapes (b) hollow square structure (d) star shape (e) and 2D lines. (f) Best 
achievable resolution by 514 µm tip. 
 
3.2.1    3D printing of 3D hair gel structures 
Once 2D hairgel structures were successfully printed as shown in Figure 3.1, 3D 
structures were designed and printed via Fab@home model 3 3D printer to investigate 
the possibility of printing 3D structures by hairgel.  
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Figure 3.2 
__
 3D printed hairgel structures (a) plus sign and (b) cone structure by Fab@Home 3.  
 
Simple 3D hair structures with limited aspect ratio were successfully printed as shown 
in Figure 3.2a. However 3D structures with a higher aspect ratio as shown in Figure 
3.2b could not be successfully printed. The first few layers were printed successfully but 
due to the lack of suitable rigidity of the hairgel, the structure started to fall apart as the 
printing progressed. At this stage, the investigation with 3D printing of complex hairgel 
structures was therefore not feasible. The results generated using hairgel printing 
provided an  improved understanding of printing alginate hydrogel.                
3.3 Preparation of partially crosslinked homogeneous alginate hydrogel to increase 
alginate hydrogel rigidity 
Non-cross-linked alginate hydrogels in general do not exhibit the required rigidity for 
printing complex 3D structures regardless of their concentrations and viscosity. 
Therefore only 2D alginate hydrogel structures could be printed. Results similar to 
hairgel 3D printing would be obtained if alginate structures with high aspect ratio were 
printed. CaCl2 solutions are used to enhance the mechanical rigidity by cross-linking the 
alginate hydrogel [32, 33]. To enhance the mechanical rigidity of alginate hydrogel, 
various alginate hydrogel and CaCl2 concentrations were used in order to form a 
homogenous partially cross-linked alginate hydrogel that might have similar mechanical 
properties to the hair gel. Alginate solutions (Product number W201502, Sodium 
Alginate, Sigma-Aldrich, Gillingham, UK) and CaCl2 solutions (Product number 
223506 CaCl2 dehydrate, Sigma-Aldrich, Gillingham, UK) at different concentrations 
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and dilutions were mixed. Sodium alginate at concentrations of 1%, 2% and 3% weight 
to volume ratio (w/v) were mixed respectively with CaCl2 solutions at concentrations of 
100 mM, 200 mM and 300 mM at dilutions of 2:1, 4:1 and 10:1. The two solutions were 
mixed and kept at room temperature overnight allowing CaCl2 to diffuse throughout the 
sodium alginate. 
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As shown in Figure 3.3, sodium alginate and CaCl2 with the same concentrations mixed 
at a 2:1 dilution ratio resulted in a fully cross-linked alginate hydrogel. At a dilution of 
4:1 sodium alginate appeared to be less rigid due to decreased dilution but the final gel 
at all concentrations was not homogenous. A 10:1 dilution resulted in a more 
homogenous gel at all three concentrations, however. 3% alginate mixed with 300 mM 
CaCl2 and diluted by 10:1 featured a much more rigid property compared to 1% and 2% 
sodium alginate respectively mixed with 100 mM and 200 mM CaCl2 at 10:1 dilution. 
Therefore 3% alginate with 300 mM CaCl2 mixture at 10:1 dilution was chosen for 3D 
printing. 
 
3.4   3D printing of 3% partially cross-linked alginate hydrogel structures  
To identify the possibility of 3D printing the 3% partially cross-linked alginate 
hydrogel, it was printed by Fab@Home with the path speed set at 6 mm/s and the 
extrusion rate set at 0.45 mL/min. As shown in Figure 3.4, the partially cross-linked 
alginate hydrogel does not have sufficient rigidity. Therefore only simple 2D structures 
could be printed. To achieve a simple 2D structure with a higher aspect ratio similar to 
the hair gel printing, a higher concentration of sodium alginate and CaCl2 were needed. 
 
 
Figure 3.4 
__
 3D printed 3% partially cross-linked alginate hydrogel by Fab@Home 3. 
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3.5   Rapid generation of partially cross-linked alginate hydrogel  
To enhance the rigidity of the gel, a higher concentration of 4% w/v sodium alginate 
and 400 mM CaCl2 were mixed at a dilution of 10:1 and then kept overnight to partially 
cross-link the gel. However, this approach for producing partially cross-linked alginate 
hydrogel was not suitable due to the time needed for the alginate to be partially cross-
linked. If cell studies are going to be carried out using bioprinting, the long wait for the 
gel would most probably affect the cell survival rate. For this reason, 8% alginate (w/v) 
and 80 mM CaCl2 were mixed at 1:1 dilution. This approach resulted in partially cross-
linked alginate hydrogel with the gel forming instantly. The gel was rigid and 
homogenous similar to the 4 % sodium alginate mixed with 400 mM CaCl2 at 10:1 
dilution that initially had a longer preparation time.  
3.6   3D printing and viscosity measurement of different range of partially cross-
linked alginate hydrogel 
Sodium alginate at concentrations of 1%, 2%, 3%, 4%, 5%, 6%, 7%, 8%, 9%, 10%, 
11 % and  12 % (w/v) were mixed with CaCl2 Solutions at concentrations of  10 mM, 20 
mM, 30 mM, 40 mM, 50 mM, 60 mM, 70 mM, 80 mM, 90 mM, 100 mM, 110 mM and 
120 mM respectively at a volume ratio of 1:1 to partially cross-link the sodium alginate 
as shown in Figure 3.5.  Various ranges of partially cross-linked alginate hydrogels 
were printed into 20 mm × 20mm × 2 mm structures to find the optimum hydrogel 
concentration with the ability to self-support. The zero shear viscosity profile 
measurement of each partially cross-linked alginate hydrogel was measured by Bohlin 
Gemini rheometer (Malvern Instruments). Dynamic viscosities of the partially cross-
linked alginate hydrogels were also measured by Gemini rheometer for 6 minutes at a 
shear rate of 1/s. 
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Figure 3.5 
__
 Prepared partially cross-linked alginate hydrogels with their relevant cross-linking 
reagents in ascending order from left to right. 
 
 
Figure 3.6 __ partially cross-linked alginate hydrogel zero shear viscosity measurements. 
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Figure 3.8 
__ 
3D printed structures (20 mm × 20 mm × 2 mm) with different concentrations of partially 
cross-linked alginate hydrogel with their relevant pre cross-linking reagents 
 
In order to fine-tune the optimal conditions for 3D printing partially cross-linked 
alginate hydrogel, a wide range of alginate hydrogels with relevant cross-linking 
conditions were prepared and printed as shown in Figure 3.8. Partially cross-linked 
alginate concentrations from 0.5% up to 2.5 % did not exhibit sufficient mechanical 
strength to self-support the printed structures shown in Figure 3.8. Higher 
concentrations of alginate at 3% and 3.5% could preserve the structure’s shape, however 
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the printed structures were too soft to maintain good structural integrity. The minimum 
alginate concentration that could self-support its structure with good structural integrity 
was found to be 4% (w/v) with final CaCl2 concentration of 40 mM. The prepared 
partially cross-linked alginate hydrogels  had viscosities ranging from 0.13 ± 0.12 Pa.s 
at 0.5% to 958 ± 69 Pa.s at 6%.  The viscosity increased exponentially with alginate 
hydrogel concentration as shown in Figure 3.6. The hydrogel with the minimum rigidity 
needed to withstand its shape had a final alginate concentration of 4% (w/v) and CaCl2 
concentration of 40 mM, and had a viscosity of 117 ± 2.5 Pa.s. There appeared to be a 
turning point in the viscosity change at around 4%. Additionally, visual inspection of 
alginate in centrifuge tubes shows 4% was also the transitional point of alginate 
concentration where more solid hydrogel was formed. 
 
3.7   3D printing of 4% partially cross-linked alginate hydrogel structures with 
higher aspect ratio 
20 mm × 20 mm × 5 mm cubic structures with were printed to investigate whether the 
4% partially cross-linked alginate hydrogel is able to support itself. 
 
 
Figure 3.9 
__   
(a) 3D printed 20 mm × 20 mm × 2 mm (b) and  20 mm× 20 mm × 5 mm by 4% partially 
cross-linked alginate hydrogel. 
 
As seen in Figure 3.9a, the 4% partially cross-linked hydrogel could be easily printed up 
to a height of approximately 2 mm. However, the gel started to collapse once the 
structure was furthermore printed above this height as shown in Figure 9b.  This was 
similar to the behaviour of hairgel as described earlier. Therefore the 4 % partially 
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cross-linked hydrogel was suitable for printing 3D structures with a limited aspect ratio 
similar to the hairgel.  
3.8   Development of a novel 3D printing technique to print complex 3D alginate 
hydrogel structures 
At this point, use of higher concentration of partially cross-linked alginate hydrogel 
would not be recommended as the viscosity would increase and shear stress applied to 
the cells during bioprinting would significantly increase and eventually damage the 
cells. A modified version of an open source Fab@Home model dual syringe extrusion-
based 3D printer was used as the main printing platform for the alginate hydrogel. It 
consisted of an automated X-Y-Z stage where the positioning precision is 100 µm. With 
its dual switchable dispensing system, it was capable of printing with a precision down 
to 100 µm in the X-Y plane as well as printing with a precision of 100 µm in the Z 
plane. Fab@Home models have previously been used to print alginate hydrogel and 
other biomaterials such as gelatine [34, 35]. A modified new Z axis carriage, shown in 
Figure 3.10, was designed and put in place to enable immersion of the Z platform into a 
100 mM CaCl2 solution bath as the secondary cross-linking reagent to further cross-link 
the printed partially cross-linked alginate hydrogel. Initially the first few layers of 
partially cross-linked alginate hydrogel are printed above the CaCl2 solution on a porous 
nitrocellulose membrane. The membrane ensures adhesion of the partially cross-linked 
hydrogel to the surface for better support while allowing CaCl2 solution diffusing into 
the structure for cross-linking. The diffusion occurs due to the higher mass 
concentration of the CaCl2 bath compared with the CaCl2 concentration in the printed 
layers outside the interface layer.  The porous membrane is connected to a thin PMMA 
(Poly methyl methacrylate) sheet with pore sizes of 0.8 mm to allow CaCl2 to enter the 
inner sections of the printed structures. The z-axis is lowered, submerging the first 
printed layers in the CaCl2 solution for further cross-linking as shown in Figure 11. The 
subsequent printing of the alginate hydrogel was supported by the partially cross-linked 
hydrogel structures above the solution.  Diffusion would also enable CaCl2 solution to 
penetrate inside the hollow sections of the printed layers as well as the layers that are 
being printed above the CaCl2 solution, forming an interface layer where rigidity of the 
hydrogel layers was sufficient to support a few layers of printed hydrogel structures. By 
repeating this sequential printing process, a complete 3D structure was generated.  
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Figure 3.10  
__
 Schematic drawing of the alginate hydrogel 3D printing setup. (a) First a few layers of 
partially cross-linked alginate hydrogel were printed on the porous membrane. At this stage the structure 
was able to support its own shape. (b) Further crosslinking of the hydrogel once the Z axis was lowered 
down and the printed partially cross-linked alginate hydrogel were submerged into the CaCl2 bath, which 
creates a better support for the upcoming layers. (c) The interface layers: upward diffusion of Ca
+2 
ions 
into the interface layers which are partially cross-linked above the CaCl2 solution. 
 
 
 
Figure 3.11 
__
 3D printing of alginate hydrogel structures showing the interface layer where partially 
cross-linked alginate hydrogel is being printed above the interface layer 
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3.9 Shear stress and viscosity  
Shear stress and viscosity play a major role in bioextrusion. The higher the viscosity 
(the resistance to flow), the higher the shear stress when the cell-laden hydrogels are 
extruded through the syringe tip. Shear stress in a pipe is defined by:  
𝜏 = 𝜇. γ 
Where 𝜏 is the shear stress,  is the viscosity and  γ is the shear rate. In a simple 
geometry with a single flow direction it is defined by   
γ =
𝑑𝑦
𝑑𝑥
 
This is measured in s
-1
. Based on the shear stress equation, increasing the viscosity and 
shear rate would increase the shear stress on the cells, causing damage to the cells. 
However, as shown in Figure 3.7 the partially cross-linked alginate hydrogel behaves 
like a shear thinning fluid, meaning an increasing the shear rate reduces the viscosity, 
making is easier for the fluid to flow. Shear thinning fluids do act like Newtonian fluids 
when subject to extreme low or high shear rates. However the power-Law region is 
where the fluid exhibits shear thinning behaviour. The shear stress in a shear thinning 
fluid in the Power-Law region can be written as: 
𝜏 = 𝑎(γ˙)𝑛Where a is a constant that describes the flow consistency of the substance 
and n is the value of power law index which usually lies in between 0.3 to 0.7 
depending upon the concentration and molecular weight of the hydrogel.  The viscosity 
can be now written as:  
𝜇 = 𝑎(γ˙)𝑛−1 
In general, an increase in viscosity enhances the rigidity of the printed structure 
however this would increase the shear stress, causing cell damage. Another important 
factor is the time that cells undergo shear stress. The longer cells are exposed to shear 
stress the greater the chance of cell damage. The effect of viscosities on cell viability is 
discussed in the next chapter. 
3.10   3D printing resolution 
To identify the best possible printing resolution, tips with different diameters were used 
to print grid structures. The grid structure dimensions were set at 3 cm × 3 cm × 2 mm. 
The tips used for 3D printing had diameters of 838 µm, 514 µm, 337 µm and 210 µm. 
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Figure 3.12 
__ 
3D printed grid structures with 4 % partially cross-linked alginate hydrogel using the 
proposed technique by 838 µm, 514 µm, 337 µm and 210 µm tip. Scale bar: 50p coin. 
  
The grid structures created are shown in Figure 3.12. The thickness of the grid 
structures printed by the 800 µm and 500 µm tips were similar, however the thickness 
of the grid structure printed by the 300 µm tip was much finer. Grid structures printed 
by 200 µm tip could not be completed as the structure was not able to hold its shape due 
to the thin nature of the printed walls. Therefore at this stage the minimum nozzle tip 
used for 3D printing was set at 337 µm diameter. 
 
3.11   3D printing alginate structures 
Figure 3.13a shows the simple 3D printed alginate hydrogel tubular structures with 
descending diameters of 20 mm, 15 mm, 10 mm, and 7.50 mm. The tubular structures 
were printed using a 0.33 mm ID nozzle. They were made of 8 printed layers each 2.5 
mm in height. All tubes had a wall thickness of 1.25 ± 0.05 mm as measured by a 
calliper. Figure 3.13b shows 10 mm diameter 3D printed alginate hydrogel tubular 
structures with 32, 24, 16 and 8 printed layers. The heights of these printed structures 
were 10.20 mm, 7.40 mm, 5.30 mm and 2.65 mm respectively. This indicated that the 
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average printing height was 322 ± 11 µm/ layer. Furthermore, complex 3D structures 
such as branched vascular structures shown in Figure 3.13d and Figure 3.13e were 
printed successfully by 0.51 mm and 0.33 mm ID tips. The height of the interface layers 
can be adjusted to ensure the best printing quality depending upon the complexity of the 
printed structures. For example, for simple 3D structures such as hollow tubes in which 
the same printing pattern was repeated, the maximum allowable distance of the interface 
layer from the nozzle tip to the CaCl2 bath was found to be 2 mm i.e. 4 layers for 0.51 
mm ID tip and 7 layers for 0.33 mm ID tip. For complex 3D angular structures it was 
0.5mm i.e. 1 layer for 0.51 mm ID tip and 2 layers for 0.33 mm ID tip. The reason for 
having a shorter distance between the nozzle tip and CaCl2 solution interface for 
bioprinting complex 3D structures was that with a large distance the partially cross-
linked alginate hydrogel was unable to support itself when printed at an angle. It was 
noticed, however, that when the nozzle tip was too close to the CaCl2 solution, 
boundaries were formed between the printed layers because the Ca
2+
 ions could easily 
diffuse into the printed layers above the CaCl2 bath. If the nozzle tip is far enough from 
the CaCl2 bath interface, the printed layers above the CaCl2 solution can merge together 
more effectively and form a more uniform and continuous construct. This new feature 
provides improved mechanical properties of the alginate hydrogel structures as well as 
the possibility to bioprint complex structures. This is consistent with recent findings on 
continuous 3D printing using the Continuous Liquid Interface Production (CLIP) 
technique [36]. This is mainly due to printing the partially crosslinked hydrogel outside 
the interface rather than inside the bath. The partially cross-linked hydrogel has 
adhesive properties, helping the printed layers to merge into each other outside the 
interface. 
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Figure 3.13 
__
 (a) Printed tube structures with reducing diameters (b) and reducing height .(c) CAD file 
of the vascular structure in Solid Edge version V20 (d) vascular structures printed by 0.51mm diameter 
tip (e) vascular structure printed by 0.33 mm diameter tip. 
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3.12  Degradation of hydrogel and the optimisation of cross-linking conditions 
This study was carried out to control and enhance the degradation time of the alginate 
hydrogel by further cross-linking it with other reagents [37].  BaCl2 solutions at 
different concentrations were used in order to achieve a suitable degradation time of the 
alginate hydrogel. The printed grid structures were exposed to 100 mM of CaCl2 for 10 
minutes and were kept in a culture medium (DMEM, 1.8mM CaCl2) for 7 days as 
shown in Figure 3.14a. The alginate structure started to break down by the second day 
and slowly degraded completely after 7 days as expected. By exposing the alginate 
hydrogel to 10 mM, 20 mM and 40 mM of BaCl2 for 2 minutes after initially being 
exposed to 100 mM of CaCl2 for 10 minutes, structural degradation was reduced in 
proportion to the BaCl2 concentration. Exposure to 10 mM of BaCl2 as shown in Figure 
3.14b was not enough to keep the printed structure in place over 7 days, as the printed 
grid structure broke down day by day although it was not completely dissolved by day 
7. Exposure to 20 mM of BaCl2 as shown in Figure 3.14c improved the degradation 
time of the alginate hydrogel. Once again, however, the structure started to crack slowly 
and any external forces could easily break the grid structure, which can cause the cells 
to escape the alginate structures. 40 mM BaCl2 as shown in Figure 3.14d was able to 
keep the structure in place over 7 days without the appearance of visible cracks within 
the grid structure. Based on the alginate hydrogel degradation results, at this stage, 40 
mM BaCl2 was the minimum concentration needed to be used as the tertiary cross-
linking reagent. The cell viability needed to be examined, however, to investigate 
whether the secondary and tertiary cross-linking process had any negative effects. 
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3.12.1 Gel degradation based on constant exposure of the gel to CaCl2 
Another set of experiments was carried out to investigate the degradation time of the gel 
when it is constantly exposed to 10 mM, 20 mM, 30 mM, 40 mM and 50 mM of CaCl2 
within the culture medium. As shown in Figure 15b, the printed gel stayed stable until 
day 5 and then started to break down on day 6. However, by the constant exposure of 
the gel to 20 mM, 30 mM, 40 mM, and 50 mM of CaCl2 the grid structures stayed stable 
over 7 days as shown in Figure 15c, Figure 15d, Figure 15e and Figure 15f respectively. 
Although the gel is kept stable, this condition might be harmful to cells. Cell studies 
therefore need to be carried out to identify the effect of constant exposure of the cells to 
CaCl2. 
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3.13 Conclusions 
In this chapter, a new printing technique for 3D printing of alginate-based hydrogel 
structures was developed. Using this new free-form fabrication technique, partially 
cross-linked alginate hydrogels were formulated with tuneable mechanical properties to 
create tubular and more complex, continuous 3D hydrogel structures. The degradation 
time of alginate hydrogel in cell culture media was investigated and the stability of the 
alginate hydrogel can be enhanced by post-printing treatment of BaCl2. This is a 
promising bioprinting technique that can be applied to fabricate clinically sized soft 
tissues with more complex and multi-cellular structures. 
 
The key working principle of the new bioprinting method is the ability to print alginate 
hydrogels with sufficiently high viscosity so that the printed structure can self-support 
and form an interface layer. In this way, new layers of fresh partially crosslinked 
alginate hydrogel can be printed onto a relatively solid substrate or the interface layer 
above the crosslinking reagent bath to build the structure layer-by-layer. However, the 
fully cross-linked hydrogel for extrusion would not be suitable because it would require 
a higher shear stress for printing. This could have an adverse effect on cell viability, in 
addition to the poor adhesion between the printed layers.  In order to achieve this 
balance, concentrations of alginate and CaCl2 solutions were developed to form partially 
cross-linked alginate hydrogel. This was designed to achieve sufficient mechanical 
rigidity with sufficiently low viscosity to avoid high printing shear stresses. A range of 
alginate concentrations (i.e. 1% w/v to 8% w/v ) and CaCl2 concentrations (i.e. 10 mM 
to 800 mM) combinations were made to produce the partially crosslinked hydrogel 
mixture for testing the best printing quality. The composition of 4% alginate and 40 mM 
CaCl2 was found to be the minimum concentration needed to create the interface layers.  
 
The next chapter investigates the cell survival rate based on this new 3D printing 
concept.  
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Chapter 4 - Live cell investigation for bioprinting 
4.1   Introduction 
In the previous chapter, 3D printing of simple and complex alginate hydrogel structures 
through a three step cross-linking process was successfully demonstrated. The chapter 
was an investigation into a new 3D bioprinting concept for bioprinting cell-laden 
alginate hydrogel structures. The key challenge of the new bioprinting concept was to 
achieve high cell viability and gel stability without compromising the cell viability. To 
optimise the printing cross-linking conditions to keep the gel stable in the long term, 
MTT assays was carried out to investigate the U87-MG cell behaviour based on various 
concentrations of cross-linking reagents. Once printing cross-linking conditions were 
optimised, the viability of the U87-MG cells right after bioprinting was assessed for 
different alginate hydrogel concentrations. The best condition was used to investigate 
the U87-MG cell viability within the bioprinted gel over 11 days. For validation of the 
new 3D bioprinting technology, a U87-MG cell line was chosen; this is an established 
human brain tumour cell line for cancer disease models with full genetic 
characterisation [1-4].  The mechanical properties of the gel were examined after 
printing based on secondary and tertiary cross-linking conditions. The ability to co-print 
was presented, demonstrating that the new bio-printing concept had the ability to 
bioprint two types of cells.  
 
4.2   Sterilisation of hydrogel for bioprinting  
In this study, sodium alginate 8% (w/v) (Product number W201502, Sodium Alginate, 
Sigma-Aldrich, Gillingham, UK) [5-8] , CaCl2 solution (Product number 223506 CaCl2 
dehydrate, Sigma-Aldrich, Gillingham, UK) and BaCl2 Solution (Product number 
1001253915 BaCl2 trace metals basis, Sigma-Aldrich, Gillingham, UK) were prepared 
in deionised water at room temperature. In addition, an ultra-sonic bath set at 60 ºC was 
used to reduce the mixing time of sodium alginate in deionised water to produce a 
homogenous solution overnight. 80 mM CaCl2, 100 mM CaCl2 and 60 mM BaCl2 were 
used respectively as primary, secondary and tertiary cross-linking reagents for 8 % 
(w/v) sodium alginate.  
 
4.3    Partially cross-linked alginate hydrogel preparation 
Sodium alginate 8% (w/v) was sterilised by Gamma radiation (IBL-637 CIS-
BioINternational gamma irradiator, France) with 10 Gy at a rate of 1 Gy/min. 80 mM 
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CaCl2 stocks were autoclaved at 121 ºC
 
for 15 minutes. The two solutions consisting of 
8% (w/v) sodium alginate and 80 mM CaCl2 were mixed with a volume ratio of 1:1 to 
result in a partially cross-linked hydrogel in a 50 mL conical tube (Centrifuge tube, 
Fisher Scientific Ltd, Loughborough, UK). The hydrogel solution was further mixed 
using a vortex mixer at room temperature at 1500 rpm for 30 seconds in order to 
produce the homogeneous partially cross-linked alginate hydrogel.  
 
 
4.4   The effect of the CaCl2 and BaCl2 cross-linking baths on the mechanical 
properties of printed hydrogels 
The partially cross-linked alginate hydrogel was printed by exposure to 50 mM, 100 
mM, 200 mM and 300 mM CaCl2 solutions to generate cubic structures with 
dimensions of 20 mm × 20 mm × 8 mm. The structures were kept in the solution for 10 
minutes followed by exposure to 60 mM BaCl2 solution for 2 minutes. A Mach-1™ 
mechanical indenter (Biomomentum, Canada) was used to measure the static stiffness. 
The partially cross-linked alginate hydrogel was also mechanically tested before 
printing to understand the role of CaCl2 in enhancing the mechanical properties of the 
gel. 
The mechanical testing suggested that the partially cross-linked alginate hydrogel had 
elastic behaviour after it was further cross-linked. The elastic moduli were 5.2 ± 0.12 
kPa, 20.18 ± 1.62 kPa, 20.87 ± 1.78 kPa and 28.24 ± 0.91 kPa with exposure to 50 mM, 
100 mM, 200 mM and 300 mM CaCl2 respectively and followed by exposure to 60 mM 
BaCl2. The partially cross-linked alginate hydrogel showed elastic behaviour with an 
elastic modulus of 1.55 ± 0.027 kPa for a strain of 1 ± 0.05 mm. Therefore the 
secondary cross-linking process (CaCl2) boosted the mechanical properties of the 
alginate hydrogel to create suitable rigidity and strength for the structure to hold its 
shape during the bioprinting process. The results shown in Figure 4.1 indicate that 50 
mM CaCl2 as the secondary cross-linking agent did not improve the mechanical 
properties of the alginate hydrogel sufficiently; it had similar mechanical properties to 
the partially cross-linked alginate hydrogel itself. However, 100 mM of CaCl2 resulted 
in a noticeable change in partially cross-linked alginate hydrogel mechanical properties, 
improving its rigidity and strength. The secondary cross-linking agent was kept at 100 
mM to prevent exposure of cells to higher concentrations of CaCl2, which could be 
harmful and affect the cell viability and function. Exposure to 60 mM BaCl2 did not 
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have a significant effect on the mechanical properties of the hydrogel in general (as 
shown in Figure 4.1). The change in mechanical stiffness upon BaCl2 treatment 
appeared less obvious when the hydrogel was cross-linked with higher CaCl2 
concentrations.        
 
 
Figure 4.1 
__
 Elastic modulus of partially cross-linked alginate hydrogel exposed to different CaCl2 
concentrations for 10 minutes followed with or without exposure to BaCl2. 
 
4.5    Cell culture and transduction for 3D bioprinting  
Human glioma U87-MG cells, purchased from the European Collection of Cell Cultures 
(ECACC) (Public Health England, UK), were seeded at a density of 0.5 × 10
6
/mL in 6-
well plates and were allowed to attach and acquire normal morphology. The cells were 
transduced using a lentiviral vector, which expresses enhanced green fluorescent protein 
(EGFP) under control of the SFFV promoter. After transduction, cells were seeded in 
96-well plates at a cell density of 0.7 cells per well, allowing the selection of a single 
transduced cell population. This was replicated for 2 weeks until a stable clone GFP1-
U87-MG line was generated. U87-MG cells were cultured in minimum essential 
medium (MEM) supplemented with 10 % (v/v) fetal bovine serum (FBS), L-Glutamine, 
non-essential amino acids (NEAA), and sodium pyruvate. All culture medium 
components were acquired from Life Technologies. During experimental procedures, 
the medium was supplemented with penicillin/streptomycin (100 UI/ml and 100 μg/ml). 
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After printing, cells were maintained at 37 °C and with 5 % CO2 in 10 cm petri dishes 
(Fisher Scientific, UK). The culture media were changed every 2 days. 
 
4.6  Manual extrusion of U87-MG cells with partially cross-linked alginate 
hydrogel  
TManual extrusion of U87-MG cells was carried out to understand the feasibility of the 
new bioprinting concept; whether the cells could stay viable and grow within the 
alginate hydrogel.  Initially, 2 mL of sterile sodium alginate was mixed with 1 mL of 
cell solution with concentration of 13.5 × 10
6
/mL. Once the cell-laden alginate solution 
was prepared it was mixed with 1 mL of CaCl2 with a concentration of 120 mM. The 
final partially cross-linked cell-laden hydrogel consisted of 4% (w/v) alginate, 40 mM 
CaCl2 and cell a concentration of 3.375 × 10
6
/ mL. The cell-laden hydrogel was loaded 
into the extrusion syringes and was manually extruded through nozzle tips of 800 µm, 
500 µm, 300 µm and 200 µm into 300 mM CaCl2 and was kept in the solution for 2 
minutes. The CaCl2 was then removed and replaced with a culture medium. Cells were 
cultured for four days and images of the encapsulated U87-MG cells were taken at day 
1, day 2, day 3 and day 4. 
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Figure 4.2 
__ 
Manual extrusion of U87-MG cells with partially cross-linked alginate hydrogel by 200 µm, 
tip. Scale bar: 100 µm. 
 
Figure 4.3 
__   
Manual extrusion of U87-MG cells with partially cross-linked alginate hydrogel by 300 
µm, tip. Scale bar: 100 µm. 
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Figure 4.4 
__ 
Manual extrusion of U87-MG cells with partially cross-linked alginate hydrogel by 500 µm, 
tip. Scale bar: 100 µm. 
 
Figure 4.5 
__ 
Manual extrusion of U87-MG cells with partially cross-linked alginate hydrogel by 800 µm 
tip. Scale bar: 100 µm. 
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The results shown in Figure 4.2 indicate that the cell number had increased on day 2 
compared to day 1. The gel started to degrade at day 2, however, and cells attached to 
the bottom of the culture dish. This could be due to the greater thickness of the cell-
laden hydrogel extruded into the CaCl2 solution where the cross-linking time was short 
and CaCl2 diffusion time was insufficient to fully cross-link the alginate. The cell-laden 
hydrogel extruded with the 200 µm, 300  µm and 500  µm tips did not fully degrade by 
day 4 as shown in Figure 4.3, Figure 4.4 and Figure 4.5 respectively, as cells 
proliferated and grew within the gel and formed small cell clusters within the gel. This 
study showed cells could stay viable and grow within the alginate hydrogel; however, 
the degradation of the gel needed to be enhanced to keep the gel stable for longer 
allowing more time for cells to proliferate within the gel.  
 
4.7   MTT assay  
MTT assay was used to determine the effect of the cross-linking reagents on U87-MG 
cells. The cell number was assessed using (3-(4,5-Dimethylthiazol-2-yl)-2,5-
diphenyltetrazolium bromide (MTT). U87-MG cells were seeded in a 96 well plate at 
7.5 × 10
4
 cells/mL and incubated overnight. Cells were then exposed to different 
conditions and the number of metabolically active cells was estimated after 24 hrs by 
measuring absorbance at 570 nm. Each condition was determined using triplicates. It 
should be noted that BaCl2 could be very toxic to cells if exposed for long-term. In a 
simple test U87-MG cells were exposed to 1% BaCl2 solution and after 24 hrs in 
culture, all cells had died. Therefore the exposure time was limited to 2 minutes. 
  
4.7.1   The effect of calcium and barium concentration on U87-MG Cells 
Based on the degradation studies from the previous chapter, this study was carried out 
to examine the effects on U87-MG cells when exposed to 100 mM CaCl2 as a secondary 
cross-linking reagent and 40 mM BaCl2 as the tertiary cross-linking reagent. U87-MG 
cells were first treated with 100 mM CaCl2 for 10 minutes, then exposed to 10 mM, 20 
mM, 40 mM, 60 mM and 100 mM BaCl2 for 2 minutes (similar to the printing 
conditions to enhance the gel degradation time [9-12]) and then cultured for 24 hours. 
The MTT assay data presented in Figure 4.6 show that after 24 hours of culture U87-
MG cells were not only unaffected negatively by exposure to BaCl2 but also the cell 
growth was seen to be reproducibly improved within 24 hours using BaCl2 
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concentrations of 60 mM and 100 mM. Based on the degradation results in chapter 3 
and MTT assay data, 60 mM of BaCl2 was therefore chosen as the tertiary cross-linking 
reagent rather than 40 mM of BaCl2. This could further enhance the alginate hydrogel 
stability and support cell growth within the alginate structure for at least 7 days or more 
as previously discussed. By visual inspection of Figure 4.7, it can be seen that the U87-
MG cells exhibited a normal morphology after 24 hrs when initially exposed to 100 mM 
CaCl2 for 10 minutes and exposed to 10 mM, 20 mM, 40 mM, 60 mM and 100 mM 
BaCl2 for 2 minutes. 
 
Figure 4.6   
__ 
MTT assay of U87-MG cells after 24 hours of culture after being exposed 100 mM of 
CaCl2 for 10 minutes and then exposed to different BaCl2 concentrations for 2 minutes. 
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Figure 4.7 
__   
Images of (a) U87-MG cells in normal culture medium after 24 hours, and U87-MG cells 
temporary exposed to (b) 10 mM, (c) 20 mM, and (d) 40 mM BaCl2 for 2 minutes and cultured in medium 
for 24 hours. Scale bar: 100 µm 
 
4.7.2   Effect of constant exposure of U87-MG cells to Calcium in the culture medium. 
This study was carried out to investigate wether constant exposure of the gel to CaCl2 
would have a positive or negative effect on cells. Gels with constant exposure to 20 mM 
and higher concentrations of CaCl2 could keep their integrity over 7 days. U87-MG 
cells were first treated with 100 mM CaCl2 for 10 minutes and then constantly exposed 
to 10 mM, 20 mM, 30 mM and 40 mM CaCl2 for 24 hours in the culture medium. Based 
on MTT assay data shown in Figure 4.8, U87-MG cells constantly exposed to 10 mM 
CaCl2 exhibited a slightly increased cell growth compared to the control, however it was 
not able to sustain its integrity and eventually started to break down and degrade after 
day 2 or day 3 in culture medium. On the other hand, U87-MG cells exhibited a 
decreased cell viability of around 20% to 25% when exposed constantly to 20 mM, 
30mM, and 40 mM CaCl2 in culture medium for 24 hours. The MTT Assay results 
based on temporary exposure of U87-MG cells to various BaCl2 concentrations and 
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constant exposure of U87-MG cells to various CaCl2 concentrations indicated that 
BaCl2  was a more effective tertiary cross-linking reagent than CaCl2,  maintaining the 
gel’s integrity over 7 days in the culture medium. On visual inspection of Figure 4.9, 
cells did not exhibit normal morphology when constantly exposed to CaCl2 present 
within the culture medium.  
 
 
Figure 4.8 
__
 MTT Assay of U87-MG cells after 24 hours of culture after being constantly exposed to 10 
mM, 20mM, 30 mM and 40 mM CaCl2 for 24 hours. 
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Figure 4.9 
__
 Images of (a) U87-MG cells in normal culture medium after 24 hours, and U87-MG cells 
constantly exposed to (b)10 mM, (c) 20 mM, (d) 30 mM and (e) 40 mM CaCl2 present within the culture 
medium for 24 hours. Scale bar: 100 µm 
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4.8   Design and 3D printing of alginate hydrogel structures 
3D printed structures were designed using the CAD program Solid Edge V20. Vascular 
structure design was extracted from online open source 3D CAD library GrabCAD. The 
CAD files were then converted to STL files and transferred to the relative software to 
generate printing paths. The partially cross-linked alginate hydrogel was loaded into the 
extrusion syringes and then nozzles with 0.33 mm ID or 0.51 mm ID (TE series 
Nozzles, OK International, Hampshire, UK) were fitted to the end of syringes. The 
printing path width was 0.35 mm and 0.55 mm with printing heights of 0.3 mm and 
0.475 mm respectively. The printing speed was 6 mm/s, which was the optimum for 
both sets of nozzles. The extrusion speeds were set to 0.45 mL/min and 0.65 mL/min 
respectively.  
 
4.9   Cell-laden alginate hydrogel solution for printing 
2 mL of 8% (w/v) sodium alginate initially was loaded with 1 mL of U87-MG cell 
suspension at a concentration of 21×10
6
/mL in the extrusion syringe. The solution was 
then mixed with 1 mL of 160 mM CaCl2 to partially cross-link the hydrogel using a 
vortex mixer at 1200 rpm for 30 seconds at room temperature.  The cell-laden alginate 
solution had final concentrations of 4% (w/v) alginate and 5.25 ×10
6
/mL cells. 
 
4.10   Live and dead cell assay 
For the visualization of dead cells in the hydrogel, propidium iodide (PI, Sigma-Aldrich 
UK) was added directly to the media in 10 cm Petri dishes (Fisher Scientific, UK) 
containing the constructs at a final concentration of 2.5 μM. After 30 minutes 
incubation in the dark at 37°C, the culture medium was removed and the coverslips 
(Cover Glass, 631-0152, VWR International USA) containing the hydrogel were 
mounted on microscope slides for imaging. 
 
4.11   3D Cell imaging and viability test 
Confocal laser scanning microscopy (Leica SP5 SMD; Leica microsystems) was used 
for image acquisition. Images were taken using a dry 20X objective. CLSM images 
were analysed using Imaris software to investigate the viability of the bioprinted cells 
over 11 days. Cell viability of the bioprinted structures at 2 %, 3 %, 4 %, 5 % and 6 % 
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of alginate concentrations (w/v) was assessed after bioprinting. Cell viability was 
quantified as the number of live cells as a proportion of the total number of cells (live 
and dead cells).  
4.12   The influence of the alginate viscosity on cell viability 
The higher the alginate concentration, the higher the shear stress needed to extrude cell-
laden hydrogels. This reduced the cell viability [13, 14]. This experiment was designed 
to understand the effect of the alginate hydrogel concentration on cell survival rate 
based on the extrusion of 2%, 3%, 4%, 5% and 6% partially cross-linked alginate 
hydrogel with their respective primary cross-linking reagent described in the previous 
chapter. The partially cross-linked cell-laden alginate hydrogel was printed into a 100 
mM CaCl2 bath, where it was kept for 10 minutes, followed by exposure to 60 mM 
BaCl2. The cell viability of bioprinted U87-MG cells in 2 %, 3 %, and 4 % (w/v) 
partially cross-linked alginates with their respective cross-linking reagents were 
maintained above 90 % immediately after bioprinting as shown in Figure 4.11. 
However, cell viability of U87-MG cells dropped to 83.8 ± 1.2 % when the 
concentration of partially cross-linked alginate hydrogel was 5% compared to the lower 
concentrations due to the higher viscosity of the cell-laden hydrogel. The cell viability 
in 6% partially cross-linked alginate hydrogel was 61.5 ± 9.8 %. This was a dramatic 
change and was due to the significant increase in viscosity of the hydrogel, being almost 
8 times the normal printing condition of 4% partially cross-linked alginate hydrogel. 
Based on the viability results, the 4% partially cross-linked alginate hydrogel was 
chosen as final concentration as lower concentrations could not keep their integrity 
during the bioprinting process as discussed in the previous chapter. Confocal images of 
U87-MG cells bioprinted in different alginate hydrogel concentrations are shown in 
Figure 4.10. 
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Figure 4.10  
__   
Confocal images of bioprinted U87-MG cells in different concentrations of alginate 
hydrogel. The grid boxes are 50 µm. 
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Figure 4.11 
__ 
Cell viability of the bioprinted cell-laden partially cross-linked alginate hydrogel 
immediately after bioprinting 
 
4.13   3D printing of U87-MG cells in 4% alginate hydrogel and its effect on long 
term cell viability 
U87-MG cells were bioprinted in partially cross-linked alginate 4% (w/v) hydrogel and 
then cross-linked with 100 mM CaCl2 for 10 minutes followed by matrix stabilisation 
with 60 mM BaCl2 for 2 minutes.  Cell viability in the 3D constructs was monitored for 
11 days post-printing as shown in confocal images in Figure 4.12. Figure 4.14 
summarises the 3D cell viability throughout the 11-day period. The bioprinted cells had 
a viability of 92.9 ± 0.9% immediately after printing at day 0. Viability then remained 
high, staying over 88% ± 4.3 %. The cross-linked alginate hydrogel maintained its 
structure over 11 days while keeping the embedded cell viability over 88 ± 4.3 % 
throughout. This indicated a suitable alginate hydrogel permeability, which allowed 
efficient diffusion of nutrients, oxygen and waste removal within the alginate hydrogel. 
Figure 4.12 showed that the U87-MG cells appeared as individual cells immediately 
after bioprinting, however, within days of culture, proliferation through to the gel 
allowed intercellular interaction implying good porosity of the alginate hydrogel. 
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Figure 4.12 
__
 Confocal images of bioprinted U87-MG cells throughout 11 days. The grid boxes are 50 
µm. 
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Figure 4.13 
__ 
  Formation of tissue-like structures within the alginate hydrogel after day 9 of culture. 
Scale bar: 100 µm. 
 
Figure 4.14  
__
 U87-MG Cell viability within 3D alginate hydrogel structures over the period of 11 days. 
Viability was assessed by choosing 3 random fields of the same construct. 
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4.14   Co-printing of partially-crosslinked alginate hydrogel 
Co-printing is a crucial area in bio-printing field due to the need for having two or more 
type of cells bio-printed in precise locations to simulate the cell placements found in 
physiological conditions [15-17]. To operate with the Fab@Home dual syringe 
extrusion system, XDFL codes were written for to extrude a ring containing 6 layers of 
gel with one print head and 3 layers of another gel with a second print head.  The co-
printed ring structure is shown in Figure 4.15.  The second hydrogel was exposed to red 
dye for visibility before 3D printing. 
 
 
Figure 4.15 
__ 
Co-printed ring with partially cross-linked alginate hydrogel followed by the 3D 
bioprinting protocol containing 6 layers of normal coloured partially cross-linked alginate hydrogel and 
3 layers of partially cross-linked alginate hydrogel with red dye. Scale bar: 1 pound coin. 
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4.16   Conclusions  
In this chapter a new free form fabrication technique was developed for the 3D printing 
of alginate-based hydrogel structures and evaluated for its applicability to 3D 
bioprinting of tumour cells.  Partially cross-linked alginate hydrogels were formulated 
with tuneable mechanical properties to create tubular and more complex continuous 3D 
hydrogel structures. The degradation time of alginate hydrogel in cell culture media was 
investigated. It was found that the stability of the alginate hydrogel could be enhanced 
by post-printing treatment with BaCl2. The proposed technique makes it possible to 
bioprint live human cells with a high cell survival rate after bioprinting. This is a 
promising bioprinting technique that could be applied to fabricate clinically sized soft 
tissues with more complex and multi-cellular structures with the potential to co-print 
two types of cells. 
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Chapter 5 - 3D fabrication of single and multiple layered alginate 
hydrogel tubular structures 
5.1 Introduction 
Conventional 2D monolayer cell culture still remains the main approach for the study of 
cell biology, regenerative medicine and drug discovery [1]. However, the relevance of 
2D cell cultures is limited compared with 3D physiological conditions, and 3D cell 
culture approaches are important in narrowing the gap between in vitro and in vivo 
studies [2-6]. Current methods for the fabrication of 3D scaffold materials include self-
assembly [7], solvent casting [8], dry freezing [9], electrospinning [10, 11] etc. 
However, the main barrier in conventional scaffold-based tissue engineering approaches 
is the inability to position living cells precisely to mimic 3D tissue. Repopulation of 
decellularised tissues and organs has been reported to regenerate 3D tissue and can be 
used as a platform for drug discovery and organ transplantation, but this approach relies 
on the availability of donated organs so cannot be scaled up indefinitely [12-14].  
3D biofabrication [15-25] is a very promising emerging field that gives experimenters 
the ability to position cell-laden bio-inks precisely into a pre-designed 3D structure. 
Recent studies on 3D bioprinted tumour models using Hela cells [4] shows the cells to 
be more chemo-resistant than  normal 2D monolayer cultures, making the 3D system a 
potentially better model for the study of real cancer cells from patient biopsies.  
There is, however, a significant problem with current 3D biofabrication approaches: 
although they can generate simple and precise 3D structures, they rely on specialised 
bio-printing machinery that is not easily accessible to many cell biologists. Therefore a 
simple, controllable and straight-forward 3D bio-fabrication method that does not 
involve complicated machinery such as bioprinting platforms would be very valuable 
for creating biomimetic 3D structures. 
 
In this chapter a new, inexpensive and simple biofabrication technique to generate 
tubular structures is presented. Alginate hydrogel was used as the main bio-ink for this 
study for its ease of use, biocompatibility and controllability over its degradation time 
[15, 26]. Further investigation is carried out to see whether this approach could also be 
used for the fabrication of complex 3D structures. The chapter mainly focuses on the 
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fabrication protocol, whereas the next chapter describes the cell studies based on the 
fabrication method. 
5.2  3D Fabrication of alginate hydrogel tubular structures by dip coating 
approach  
Stainless steel metal bars were chosen because of their wettability. Bars with a range of 
diameters (down to 600 µm) were used as the mould for tubular structure fabrication. 
The metal bars were kept in ethanol overnight to sterilize them prior to use. As depicted 
in Figure 5.1a, the mould was first dipped into a 6% w/v sodium alginate solution for 
approximately 3 seconds and then removed. A thin layer of the cell-laden hydrogel was 
left coated on the surface of the metal bar. The metal bar was then dipped into filter-
sterilized cross-linking reagents (100 mM CaCl2 or 55mM BaCl2) for 2 minutes to 
cross-link the sodium alginate of the coated layer shown in Figure 5.1b The cross-linked 
cell-laden alginate hydrogel was then gently pulled off using tweezers from one end of 
the metal bar mould, leaving a hollow tubular structure of cross-linked cell-laden 
hydrogel shown in Figure 5.1c. Optimization of cross-linking is discussed later in the 
chapter.  
 
 
Figure 5.1 
__
 Schematic drawing of the alginate hydrogel tubular structure fabrication process, (a) a 
metal bar mould is dipped into 6% w/v sodium alginate to coat the surface by a thin layer of cell-laden 
alginate hydrogel, followed by (b) the exposure to 55 mM BaCl2 or 100mM CaCl2 to fully cross-link the 
sodium alginate layer for 2 minutes and then (c) the cross-linked alginate layer is pulled off the mould as 
a hollow tube. 
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5.3   Fabrication methodologies 
Based on the fabrication proposal, different experiments were designed to find the 
optimum conditions such as sodium alginate, BaCl2 and CaCl2 concentrations as well as 
the cross-linking time of the sodium alginate. 
5.3.1 Alginate hydrogel tubular structure fabrication optimisation by CaCl2 cross-
linking reagent   
5.3.1.1   Alginate hydrogel tubular structure fabrication by short exposure to different 
CaCl2 concentrations  
This experiment was carried out to find the minimum concentration of CaCl2 needed to 
cross-link the 8 % (w/v) sodium alginate to form a hollow tubular structure within 10 
seconds on a 3 mm diameter stainless steel bar mould. The ability to form a tubular 
structure with the planned conditions is listed in Table 1 along with the ease of removal 
from the mould. 
Constant parameters and variables during the experiments were as follows. The mould 
bar diameter was 3 mm, the sodium alginate concentration was 8% (w/v) and the cross-
linking time was set at 10 seconds.  
Table 5.1 
__
 Optimisation of the CaCl2 concentration needed to cross-link 8% (w/v) sodium alginate on 
3 mm mould bar at 10 seconds. 
CaCl2 concentration 
(mM)  
Tube structures formed 
or not? 
Easy to remove from the 
mould?  
1000 Yes Yes 
900 Yes Yes 
800 Yes Yes 
700 Yes Yes 
600 Yes Yes 
500 Yes Yes 
400 Yes Yes 
300 Yes No 
200 Yes No 
100 Yes No 
50 No No 
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Based on the results shown in Table 5.1, 8% (w/v) sodium alginate was cross-linked at 
10 seconds and easily removed when cross-linked by 400 mM to 1000 mM CaCl2. 
When cross-linked with 300 mM CaCl2, the tube structure was formed around the 
mould, but it was very fragile and without care it would easily collapse. Alginates cross-
linked by 100 mM and 200 mM were still able to from the tubular structures, but 
extremely fragile and needed to be removed with extreme care. At 50 mM the alginate 
was not cross-linked and no tubular structure was formed.  
5.3.1.2 Alginate hydrogel tubular structure fabrication by different cross-linking 
timings  
On the basis of observations of the formation of the tube structure around the mould bar 
by 8% (w/v) sodium alginate cross-linked by minimum CaCl2 concentration of 100 mM, 
another experiment was designed to determine the effect of cross-linking time. This was 
done to optimise the minimum needed time to cross-link 8% (w/v) alginate hydrogel 
coated on a 3 mm mould by 100 mM CaCl2 cross-linking reagent. The results are listed 
in Table 5.2 below.          
Constant parameters and variables during the experiments were as follows. The 
tube/mould diameter was 3 mm, sodium alginate was 8 % (w/v) and CaCl2 
concentration was set at 100 mM.  
Table 5.2  
__
   Minimum time needed to cross-link 8% (w/v) sodium alginate coated on a 3 mm mould/tube 
to form rigid hollow tubular structures by 100 mM CaCl2. 
Time (seconds) Could tube structure be 
formed and easily be removed 
without falling apart? 
10 No 
20 No 
30 No 
40 No 
50 No 
60 No 
70 No 
80 No 
90-120 Yes 
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The results shown in Table-2 indicate that a cross-linking time of 90 seconds or more 
was suitable for cross-linking alginate hydrogel to form tubular structures that could be 
easily removed.  A cross-linking time of less than 90 seconds resulted in the failure of 
tubular structure fabrication.  
 
5.3.1.3 Alginate hydrogel tubular structure fabrication by long exposure to different 
CaCl2 concentrations 
This test was carried out to find out the minimum concentration of CaCl2 cross-linking 
reagent at 25 minutes needed to cross-link the alginate to create hollow tubular 
structures apart with a reasonable uniformity and rigidity that can be removed easily 
without falling.  
Constant Variables for this experiment were as follows. The Sodium alginate 
concentration was 8 % (w/v), the cross-linking time was 25 minutes and a mould 
diameter of 3 mm was used. 
 
Figure 5.2 
__
 Fabricated 8 % alginate hydrogel tubular structures by 3 mm mould bar cross-linked with 
(a) 20 mM (b) 30 mM and (c) 40 mM of CaCl2 cross-linking agent for 25 minutes. Scale bar: 5p coin. 
 
At 10 mM CaCl2, alginate was cross-linked and a tubular structure was formed on the 
mould’s surface. Once removed from the mould, however, it was fragile and 
collapsedmould. At 20 mM and 30 mM CaCl2, shown in Figure 5.2a and Figure 5.2b, 
tubular structures that could be removed from the mould by extreme care were formed. 
The tubes did not feature appropriate uniformity and rigidity, however. At 40 mM as 
shown in Figure 5.2c, the tubular structure was easily removable and featured good 
uniformity and rigidity.  
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5.3.1.4 Fabrication of tubular structures by different alginate concentrations with 
exposure to 40 mM CaCl2 
With the first three set of experiments, the minimum CaCl2 concentrations needed to 
form uniform and rigid tubular structure with 8 % (w/v) sodium alginate solution were 
40 mM for long exposure and 100 mM for short exposure. A new test was carried out to 
find the minimum possible concentration of sodium alginate to form uniform tubular 
structures when cross-linked with 40 mM CaCl2 at long exposure.  
Constant variables for this experiment were as follows. The CaCl2 concentration was 40 
mM, the cross-linking time was set to 25 minutes and the mould diameter was 3 mm. 
 
Figure 5.3 
__
 Fabricated (a) 8%, (b) 7% and (C) 6% (w/v) alginate hydrogel tubular structures cross-
linked with 40 mM CaCl2 for 25 minutes. Scale bar: 5p coin.  
 
As previously mentioned uniform and rigid alginate 8% alginate hydrogel structures 
were fabricated by exposure to 40 mM CaCl2 for 25 minutes shown in Figure 5.3a. As 
shown in Figure 5.3b, a 7% alginate hydrogel tubular structure was also formed when 
cross-linked by 40 mM CaCl2 for 25 minutes, however it needed to be removed from 
the mould with extreme care to maintain its integrity. At this stage, it was clear that 
lowering the alginate concentration to 6% would result in a tubular structure with poor 
rigidity, collapsing as shown in Figure 5.3c. 
Based on the results obtained from the four experiments, the cross-linking reagent for 
further experiments was chosen as 100 mM CaCl2 for 2 minutes (short exposure) due to 
its lower concentration and shorter time needed to cross-link the alginate.  
 
5.3.2   Fabrication of alginate hydrogel tubular structure by BaCl2 cross-linking agent 
This experiment was carried out to find the minimum concentration of BaCl2 needed to 
fabricate alginate hydrogel tubular structures that are sufficiently rigid to keep their 
integrity once removed from the 3 mm mould bar after 2 minutes. A similar fabrication 
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procedure was followed as cross-linking the alginate with CaCl2. Initially, the 3 mm rod 
mould was dipped into 8% sodium alginate and then into 10 mM, 20 mM, 30 mM, 40 
mM, 50mM and 60 mM of BaCl2 for 2 minutes. 2 minutes of cross-linking time was 
used due to the high toxicity of the BaCl2, which could be harmful to the cells used 
during future studies. It would also be a good comparison to the alginate hydrogel 
tubular structures fabricated with CaCl2 cross-linking reagent for 2 minutes.   
 
Figure 5.4 
__
 Fabricated alginate hydrogel tubular structures by exposure to (a) 10 mM (b) 20 mM (c) 30 
mM (d) 40mM (e) 50 mM and (f) 60 mM BaCl2 cross-linking reagent for 2 minutes and removed from the 
mould. Scale bar: 1 pound coin 
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Based on the results, the 8% (w/v) sodium alginate coated on the mould’s surface was 
not cross-linked after exposure to 10 mM of BaCl2 for 2 minutes as shown in Figure 
5.4a, which indicated that the BaCl2 concentration was too low at this stage. On the 
other hand, 8% (w/v) sodium alginate cross-linked by 20 mM, 30 mM and 40 mM 
resulted in formation of sufficiently rigid tubular structures on the mould’s surface. 
Once removed from the mould, however, the tubular structures were not able to keep 
their integrity and collapsed as shown in Figure 5.4b, Figure 5.4c and Figure 5.4d. 
Fabricated tubular structures cross-linked with 50 mM and 60 mM BaCl2 had suitable 
rigidity and integrity as shown in Figure 5.4e and Figure 5.4f. The 8% sodium alginate 
cross-linked with 50 mM BaCl2 had a minor deflection once removed from the mould;, 
60 mM BaCl2 resulted in a uniform and rigid tubular structure, however. A BaCl2 
concentration of between 50 mM to 60 mM was therefore considered to be the suitable 
range for cross-linking for 2 minutes. 
 
5.4   Fabrication of alginate-gelatine tubular structures  
Fabrication of alginate-only tubular structures with an optimised cross-linking condition 
was successfully presented in the previous section. A new experiment was designed to 
identify the ability of this technique to incorporate other biocompatible materials such 
as gelatine [27-29] with sodium alginate to fabricate tubular structures.  Gelatin-alginate 
solution at gelatine concentration of 4% (w/v) (Gelatin from porcine skin, Type A, 
Sigma-Aldrich, UK) and sodium alginate at 6% was prepared in deionised water. A 3 
mm rod/mould was dipped into the gelatine-alginate solution for 3 seconds to coat the 
mould’s surface. Once the biomaterial was coated on the mould’s surface, it was then 
dipped into the cross-linking reagents for 2 minutes (100 mM CaCl2 or 55 mM BaCl2) 
for cross-linking the sodium alginate present in the alginate-gelatin composition, 
forming the hollow tubular structure. As shown in Figure 5.5, the dip coating method 
had the ability to fabricate alginate-gelatine tubular structures that could have the 
potential to incorporate other biomaterials such as gelatine as well. 
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Figure 5.5 
__
 Fabricated alginate-gelatine tubular structure by the dip-coating approach. Scale bar: 5p 
coin. 
 
5.5   Fabrication of gelatine-only tubular structures 
In order to fabricate gelatine tubular structures, gelatine-alginate tubular structures were 
fabricated using the dip-coating approach with the gelatine-alginate solution at 
concentrations of 4% (w/v) and 6% (w/v) respectively, cross-linked with 100 mM CaCl2 
or 55 mM BaCl2 for 2 minutes. Once the gelatine-alginate tubular structure was 
fabricated as shown in Figure 5.6a, 400 µL of Ethylenediaminetetraacetic acid (EDTA) 
was added to dissolve the sodium alginate (Figure 5.6b) present within the tubular 
structure to leave a gelatine only tubular structure as shown in Figure 5.6c. 
 
Figure 5.6 __ Fabrication of gelatine-only tubular structures processed with the dip-coating approach. 
(a) Initially, alginate-gelatine tubular structures were fabricated. (b) 400 µL of EDTA was added to the 
tubular structures to dissolve the sodium alginate present within the tubular structures to form a (c) 
gelatine-only tubular structure. Scale bar: 5p coin. 
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The gelatine concentration at 4% (w/v) did not provide sufficient rigidity to keep the 
integrity of the tubular structure once the the sodium alginate was dissolved. Gelatine-
alginate solutions with higher gelatine concentrations of 6%, 8% and 10% (w/v) were 
therefore prepared to fabricate gelatine tubular structures. The same cross-linking 
procedure was followed and the tubular fabricated structures can be seen in Figure 5.7. 
The results for 4%, 6% and 8% as shown Figure 5.7a, Figure 5.7b and Figure 5.7c 
respectively indicated that the tubular structure could not keep its integrity. Although at 
10% the structure still collapsed, much improvement was observed in the rigidity of the 
tubular structure. As an example the tubes could keep their integrity within the culture 
medium as it would provide support for the tubular structure.    
 
Figure 5.7 
__
 Fabricated gelatine tubular structures at (a) 4% (b) 6% (c) 8% and (d) 10% (w/v) via dip-
coating approach. Scale bar: 5p coin. 
 
5.6  Fabrication of different sized alginate hydrogel tubular structures with 
various alginate concentrations 
Tubular structures with different inner diameters ranging from 0.6 mm, 1.2 mm , 2.5 
mm, 3 mm, 4 mm and 6 mm were successfully fabricated with 6 % (w/v) alginate 
hydrogel solution using the dip-coating method by exposing them to crosslinking 
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reagents as shown in Figure 5.8. The cross-linking reagents used were 100mM CaCl2 
solution or 55 mM BaCl2 solution.  The thickness of the fabricated tubes with inner 
diameters of 0.6 mm, 1.2 mm, 2.5 mm, 3 mm, 4 mm and 6 mm  measured by calliper,  
were 126 ± 6 µm, 143 ± 5 µm, 171 ± 9 µm, 181.6 ± 13  µm, 206.6 ± 6 µm and 220 ± 7 
µm respectively as shown in Figure 5.9. The results indicated an interesting correlation 
between the tube thickness and inner diameter of the tube.. To optimise the layer 
thickness of the tubular structures, alginate hydrogel solutions at 5%, 6%, 7% and 8% 
(w/v) concentrations were used to fabricate tubular structures. According to the 
measurements, the increase in thickness of the tubular structures was approximately 
linear with increasing sodium alginate concentrations. 5% alginate hydrogel 
concentration was the minimum concentration needed to fabricate tubular structures. 
Lower concentrated fabricated tubular structures had insufficient rigidity to support the 
integrity of the structure. It should be noted that this minimum is probably specific to 
the sodium alginate used in this study and that other sodium alginates with different 
viscosities and molecular weights may require different alginate concentrations and 
different concentrations of cross-linking reagents to fabricate the tubular structures. This 
may or may not result in a tubular structure with different wall thicknesses.   
 
 
Figure 5.8 
__
 Alginate hydrogel tubular structures fabricated by the dip-coating method. Fabricated 
single layer alginate hydrogel tubular structures with descending diameters from left to right. Scale bar: 
5p coin. 
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Figure 5.9 
__
 Sodium alginate concentration and mould diameter effect on fabricated tubular structure 
wall thicknesses. 
5.7   Fabrication of multi-layer alginate hydrogel tubular structures 
After confirming the ability to produce single layer tubular structures, feasibility studies 
were performed to understand the ability of the dip-coating approach to fabricate 
multilayer alginate hydrogel tubular structures. To fabricate multilayer alginate 
hydrogel tubular structures, the mould was dipped into sodium alginate 6% (w/v) for 3 
seconds and then dipped into the cross-linking reagent (100 mM CaCl2 or 55mM BaCl2) 
for 2 minutes to cross-link the sodium alginate on the mould’s surface to form the first 
layer of the tubular structure. The cross-linked layer was then dipped into to the sodium 
alginate once more for 3 seconds whilst still on the mould to be coated by the second 
layer of sodium alginate. It was then dipped into the cross-linking reagent (100 mM 
CaCl2 or 55 mM BaCl2) for another 2 minutes to cross-link and form the second layer. 
This procedure could be repeated as many times as preferred to reach the number of 
layers within the tubular structure as desired as shown in Figure 5.10. The dip-coating 
approach allows the fabrication of tubes smaller than 1 mm up to various diameters, as 
well as the possibility to optimise the thickness of the tubes depending upon the desired 
application. This approach could potentially place different cell types within each layer 
with the ability to fine tune each layer to the desired thickness upon the application. The 
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tube wall thickness after the dip-coating was dependent on the wettability of the coating 
surface, however. Therefore the wall thickness of the secondary layer would depend on 
the wettability of the first coated layer and hence the thickness of the second layer may 
vary with different batches of material from the data presented here.   
 
  
Figure 5.10  
__
  Fabricated multilayer alginate hydrogel tubular structures (a) Two layers, (b) three 
layers, (c) four layers and (d) overview of the fabricated one, two, three and four layer tubular structures 
fabricated via dip-coating approach. Scale bar: 20p coin. 
 
5.8   Flow experiment through cross-linked alginate hydrogel tubular structures  
The flow experiment was designed to investigate whether the fabricated alginate 
hydrogel tubular structures were sealed against liquid flow. An alginate hydrogel 
tubular structure with 4 mm diameter was fabricated using the dip-coating protocol. 60 
mL of water with red dye was prepared and loaded into the syringe. The syringe was 
then loaded into the syringe pump and the tubular structure was fitted with the syringe 
tip. The syringe pump flowrate was set to 20 mL/min for 3 minutes. 
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Figure 5.11 
__
 Water flow through a fabricated 4 mm inner diameter alginate hydrogel tubular structure. 
 
As shown in Figure 5.11, the tubular structure was completely sealed from the start to 
the end of the flow providing a safe and sealed environment for liquid flow through the 
tubular structure.  
A similar experiment was carried out to ensure the tubular structures are fluid tight as 
well under water. Initially, alginate hydrogel tubular structure with 4 mm diameterwas 
fabricated using the dip-coating protocol. 60 mL of water with red dye was prepared 
and loaded into a 60 mL syringe. The syringe was then loaded into the syringe pump 
and the tubular structure was fitted with the syringe tip. The tubular structure then was 
passed through water and one end was left to discharge the water with red dye. The 
syringe pump flowrate was set to 20 mL/min for 3 minutes.  As shown in Figure 5.12 
the tubular structure was completely sealed from the start to the end of the flow and 
provided a safe and sealed environment for liquid flow through the tubular structure in 
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both water and air. Experiments based on this approach could possibly mimic blood 
flow through vessels.  
 
Figure 5.12
__ 
Flow experiment through a single layer alginate hydrogel tubular structure. Water with red 
dye was pumped from a syringe, through the fabricated tube to the beaker on the right. The red dye was 
transferred and did not leak either into water (the beaker on the left) or air (note the absence of dye on 
the table). 
 
5.9  3D fabrication of complex alginate hydrogel structure 
5.9.1 3D printing branched structure and its silicone-based mould fabrication 
Successful 3D fabrication of single and multiple layered tubular structures was 
presented in the previous section.  To move to more complex 3D structures such as 
branched structures, the use of metal bars would not allow for removal of the cross-
linked alginate or other biomaterials. Therefore the proposed idea was to fabricate a 3D 
mould using dissolvable material at 37 °C. This meant that once the alginate hydrogel 
was coated on the mould’s surface and cross-linked, the mould should be dissolved 
when cultured at 37 °C, leaving behind the complex cross-linked alginate hydrogel 
structure. In order to fabricate the mould, a branched structure design was extracted 
from Garb-CAD, a free CAD library, and then 3D printed by MakerBot Replicator 2X 
ABS 3D printer as shown in Figure 5.14. Once 3D printed, a silicone mould of the 
branched structure was fabricated as shown in Figure 5.15. Silicone Sylgard 184 (Down 
Corning, UK) with a base to cross-linker ratio of 10:1 (v/v) was prepared. A 3 mm thick 
layer was poured into a plastic tank measuring 6 cm × 11 cm × 4 cm and was cured at 
90 °C for an hour. Then the printed branched structure was placed on top of the cured 
layer. An uncured silicone at 17 mm layer thickness was poured into the tank containing 
the branch structure. The silicone was then cured at 90 °C for another hour. Once cured, 
a 7.6 µm thick layer of polyamide was put on the cured silicone. Another layer of 
uncured layer of silicon was added on top until the branch structure was covered fully 
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with silicone. It was left for two hours at 90 °C to cure. Once cured, the silicone was 
taken out. The polyamide sheet helped to keep the two main sections of the mould 
separate.   
 
Figure 5.13 
__  
Schematic drawing of 3D biofabrication of complex alginate hydrogel structure via dip-
coating using a dissolvable mould.  (a) 3D printed solid branched structure (b) was put in an uncured 
silicon to form its (c) mould once the silicon was cured.  (d) Water was poured into the mould and kept in 
the freezer overnight. Once an ice mould was formed, it was dipped in alginate hydrogel to be coated by 
a layer of alginate and then (f) was dipped into CaCl2 solution until the ice melted, resulting in a (g) 
hollow branched structure made of cross-linked alginate hydrogel.  
  
 109   
 
 
 
Figure 5.14 
__
 3D printed solid branched structured using ABS plastic by MakerBot Replicator 2X.Scale 
bar: 1p coin. 
 
 
Figure 5.15 
__ 
Fabricated silicone mould for the solid branched structure. Scale bar: 1p coin. 
 
5.9.2 Fabrication of dissolvable mould and hollow alginate hydrogel branched 
structure  
To understand the feasibility of this 3D fabrication approach, water at room temperature 
was injected into the silicon mould and was kept in the freezer at -17 °C for 3 hours. 
The ice mould was removed as shown in Figure 5.16 and dipped into an 8% (w/v) 
sodium alginate solution and then immediately dipped into a 300 mM CaCl2 at room 
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temperature for two minutes. This dissolved the ice and cross-linked the alginate as 
shown in the Figure 5.17, forming a hollow branched structure.   
 
Figure 5.16  
__
 Fabricated solid ice branched structure from a silicone mould. Scale bar: 50p coin. 
 
 
Figure 5.17 
__ 
Fabricated Hollow branched cross-linked alginate hydrogel structure using solid ice 
mould. 
 
An ice mould was used to validate the feasibility of using dissolvable materials to form 
complex alginate hydrogel structures such as the branched structure shown in Figure 
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5.17. However, the use of ice could be harmful to the cells due to its low temperature, 
limiting the possibility of using the cells for subsequent cell studies. Therefore a 
biocompatible and dissolvable mould with a higher melting point, such as gelatine with 
a melting point of 37 °C, would be more appropriate. 
 
5.9.3 Fabrication of a complex alginate hydrogel structure using gelatine mould  
Gelatine is a highly biocompatible material and has a higher melting point than ice. To 
fabricate the solid gelatine mould, 20 % w/v gelatine from porcine skin was prepared in 
de-ionised water at 60 °C to keep the gelatine solution in a liquid state. A solid stomach 
at 1:2 scale was created in 3D by MakerBot Replicator 2X, similar to the branched 
structure shown in Figure 5.18a. A silicone mould of the solid stomach was fabricated 
shown in Figure 5.18b. The gelatine solution was poured into a silicone mould and left 
at room temperature for an hour to cool down to solidify. The solid gelatine stomach 
structure shown in Figure 5.18c was gently removed from the silicon mould and then 
dipped into 8% (w/v) sodium alginate to be coated by a layer of alginate. It was then 
dipped into 300 mM CaCl2 solution at room temperature to cross-link the alginate to 
form a hollow stomach structure as shown in Figure 5.18d. Dissolving the gelatine 
would take more time compared to ice. However, if cell study is needed to be carried 
out, the cell-laden cross-linked alginate could stay coated on the gelatine due to 
gelatine’s biocompatibility as long as both gelatine and alginate solutions are sterile. 
The cross-linked cell-laden alginate hydrogel could therefore possibly be incubated at 
37 °C and the dissolution time of the gelatine would be insignificant. 
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5.10   Conclusions 
In this chapter, a new rapid 3D biofabrication technique was developed for multi-
layered alginate hydrogel tubular structures, bypassing cell sheet technologies [30-33] 
and other complex tubular fabrication approaches [33-41] that require expensive and 
complicated machinery systems.  Tubular structures from the submillimetre range to 
greater diameters with the ability to control the thickness of the tube walls can be 
fabricated using the dip-coating approach. This approach could incorporate other bio-
materials within the alginate hydrogel to help cell biologists bypass the lengthy, 
complicated and expensive fabrication approaches. It would allow integration of the 
dip-coating method to fabricate 3D tubular structures with living cells in the preferred 
extracellular matrix. By making some alterations to the tube fabrication protocol, 3D 
fabrication of complex 3D structures such as hollow branched structure and hollow 
stomach was achievable. 
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Chapter 6 - Biological studies based on dip-coating approach 
6.1   Introduction 
In the previous chapter, rapid fabrication of tubular structures made of alginate hydrogel 
was demonstrated using the dip-coating approach, as well as the composition of the 
alginate hydrogel with other biomaterials. Rapid fabrication of complex 3D structures 
such as a branched structure and a stomach were demonstrated using the dip-approach, 
as well using a dissolvable mould.  In this chapter the biological studies cover 
sterilisation methods other than the Gamma sterilisation used for 3D bioprinting in 
chapter 4. The methods were used to sterilise the alginate to investigate cell attachment 
on alginate hydrogel based on the different sterilisation methods. Madin-Darby canine 
kidney cells (MDCKII cells) and mouse dermal embryonic fibroblast cells were 
fabricated into tubular structures using different biomaterials and various cross-linking 
conditions over 6 days of culture. The cell viability was subsequently tested. Cell 
function within the tubular structures fabricated by the dip-coating approach was tested 
using the human embryonic kidney cells (tHEK). In addition, new biomaterial 
compositions were tested to enhance the cells’ attachments on the biomaterial’s surface 
using MDCKII cells, mouse dermal fibroblast cells, U87-MG cells and Human 
fibroblast cells. 
 
6.2   Cell culture  
All cell lines used in this study were cultured in 5.0 % CO2 at 37.0 °C. Human 
embryonic kidney 293 cells containing a tetracycline responsive red fluorescence 
protein (tHEK) were kindly donated by Dr. Elise Cachat (Centre for integrative 
physiology, Edinburgh University, UK) and cultured in Dulbeccos Modified Eagle 
Medium (DMEM, Sigma D5796) with 5 % Fetal Bovine Serum (Biosera, FB-
1090/500). Mouse dermal embryonic fibroblasts that were kindly donated by Mrs. 
Audrey Peter (College of Medicine & veterinary Medicine, Edinburgh University, UK) 
were cultured in Minimum Essential Medium (MEM, Sigma M5650) supplemented 
with 5 % Fetal Bovine Serum and 1 % L-Glutamine (Invitrogen, 25030-081).  
Human glioma U87-MG cells, originally purchased from European Collection of Cell 
Cultures (ECACC) (Public Health England, UK), were seeded at the density of 0.5 × 
10
6
/mL in 6-well plates and were allowed to attach and acquire normal morphology. 
Then the cells were transduced using a lentiviral vector which expresses enhanced green 
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fluorescent protein (EGFP) under control of the SFFV promoter. After transduction, 
cells were seeded in 96-well plates at a cell density of 0.7 cells per well, allowing the 
selection of a single transduced cell population which were replicated for 2 weeks until 
a stable clone GFP1-U87-MG line was generated. U87-MG cells were cultured in 
minimum essential medium (MEM) supplemented with 10 % (v/v) fetal bovine serum 
(FBS), L-Glutamine, non-essential amino acids (NEAA), and sodium pyruvate. All 
culture medium components were from Life Technologies. During experimental 
procedures, medium was supplemented with penicillin/streptomycin (100 UI/ml and 
100 μg/ml). After printing, cells were maintained at 37 °C and with 5 % CO2 in 10 cm 
petri dishes (Fisher Scientific, UK). The culture media were changed every 2 days. 
 
 
6.3   Fabrication of sterilised 2D Alginate sheets to culture MDCKII cells 
I8% (w/v) sodium alginate solution (Product number W201502, Sodium Alginate, 
Sigma-Aldrich, Gillingham, UK) was prepared in deionized water. An ultrasonic bath 
was used overnight at 60 °C to ease the mixing process. 100 mM CaCl2 solution 
(Product number 223506, CaCl2 dehydrate, Sigma-Aldrich, Gillingham, UK) was 
prepared in deionised water as the cross-linking reagent. Two sets of sheets were 
prepared for culture purposes. 
400 µL of alginate was poured on a 60 mm petri dish and was spin coated. 100 mM 
CaCl2 was poured on the alginate layer and was kept there for 2 minutes. Once the 
alginate was cross-linked, it was cut into 1 cm × 1 cm sheets using a razor and kept in a 
50 mM CaCl2 solution to keep its shape. 
In addition to sheets that were not sterile, three different sterilisation techniques were 
used to sterilise the alginate sheets before cell seeding: 
1. Autoclaving: The sheets were autoclaved for 2 hours at 120 °C. 
2. UV radiation: The sheets were transferred to distilled water and incubated at room 
temperature overnight in a tissue culture hood under UV radiation. 
3. Chloroform: The chloroform was added to deionised water so that it formed a bottom 
layer and did not mix; this was done in a fume hood. The sample was then left overnight 
in a fume hood so that the chloroform evaporated through the water and alginate to 
sterilise the sample. All samples were washed with medium (minimal essential medium, 
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fetal bovim serum (FBS) and 1% Penicillin/streptomycin) before transferring to cell 
culture treated six-well plates.  
Once the sterilisation process was performed the alginate sheets were transferred into a 
6 well plate and 0.3 ×10
6
 MDCKII cells in 5 mL of medium were added into each well. 
The cultures were then left for 5 days at 37 °C, 5% CO2 before imaging.   
 
6.3.1   Fabrication of 2D alginate sheets with rat collagen type 1 
0.67 mL of 0.4% (w/v) collagen type 1 from rat tail dissolved in 20 mM acetic acid 
(Product number C3867, Sigma-Aldrich, Gillingham, UK) was added to 1.33 mL of 8 
% (w/v) sodium alginate and mixed with an ultrasonic bath at room temperature for 2 
hrs. This resulted in a solution consisting of 0.133% (w/v) collagen and 6% (w/v) 
sodium alginate. 400 µL of the solution was placed on a 60 mm Petri dishes and was 
spin coated. 100 mM CaCl2 was added for 2 minutes to cross-link the alginate sheet. 
Once cross-linked the sheet was cut into smaller sheets of 1 cm × 1 cm and was kept in 
50 mM CaCl2 solution to keep its shape. The sheets with rat collagen used the same 
procedure of cell seeding as was performed on the alginate only sheets. The images 
shown in Figure 6.1 represent the results based on a 5-day culture with different 
sterilisation processes. 
  
 122   
 
 
Figure 6.1 
__
 Seeded MDCK cells on a (a) non sterile cross-linked alginate sheets and sterile cross-linked 
alginate sheets by (b) autoclave, (c) UV radiation and (d) Chloroform. Scale bar: 100 µm. 
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Figure 6.2 
__ 
Seeded MDCK cells on a (a) non sterile cross-linked alginate-collagen sheets and sterile 
cross-linked alginate-collagen sheets by (b) autoclave, (c) UV radiation and (d) chloroform. Scale bar: 
100 µm. 
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6.4    Increase in concentration of rat-collagen in alginate-rat collagen 2D sheets  
Based on the results shown in Figure 6.1 and Figure 6.2, the collagen seems to be 
enhancing adhesion of MDCK II cells to the cross-linked alginate hydrogel sheets. 
Therefore to improve the cell attachment, an increase in collagen concentration could be 
beneficial.  To increase the concentration of collagen, 0.12 g of sodium alginate was 
directly added to 2 mL of 0.4% (w/v) collagen. This resulted in a solution with 0.4% 
(w/v) collagen and 6% (w/v) sodium alginate. An ultrasonic bath at room temperature 
was used to reduce the mixing process duration to 1 hr. Once the solution was ready, it 
was dispensed on the centre of a 12 mm hydrophilic Petri dish and then spin coated. 100 
mM CaCl2 solution was poured on the gel for 2 minutes to cross-link the sodium 
alginate. The calcium was removed and the cross-linked sheet was cut into identical 
pieces of 1 cm × 1cm and kept in a 50 mM CaCl2 solution to keep their shapes. The 
sheets then were sterilised by autoclave, chloroform and UV radiation as per the 
protocol in section 6.1. The sheets were then moved to the bottom of a 6 well plate 
culture dish. 0.3 ×10
6
 MDCKII cells in 5 mL culture medium were seeded on the well 
plates. The images shown in Figure 6.3 show the adhesion of MDCKII cells on 
alginate-collagen sheets after 5 days of culture.  
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Figure 6.3 
__
 MDCKII cells seeded on (a) non sterile cross-linked alginate and alginate-collagen sheets 
and seeded cells on cross-linked alginate and alginate-collagen sterilised by (b) UV radiation, (c) 
chloroform and (d) autoclaving. 
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Alginate sterilisation by chloroform resulted in better adhesion of the cells to the cross-
linked alginate sheet and alginate-collagen sheets compared to the other sterilisation 
methods. However, the formation of clusters on top of the hydrogel sheet was not 
acceptable and a better morphology was required. A similar alginate sterilisation 
method as used previously in chapter 4 for bioprinting of U87-MG cells was therefore 
was used for further studies in this chapter due to the formation of tissue-like structures 
within the gel. 
 
6.5   Fabrication of 3D hydrogel tubular structures encapsulated with MDCKII 
cells 
Sodium alginate at 8% (w/v) and collagen type 1 from rat tail were used as scaffold 
biomaterials for this 3D biofabrication process. 100 mM CaCl2 and 55 mM BaCl2 
(Product number 34290, BaCl2, Sigma-Aldrich, Gillingham, UK) were used as the 
cross-linking reagents. Metal bars used for cell experiments were purchased from OK 
International and the metallic parts were extracted from the needles (TE718150PK, OK 
International). Sodium alginate 8% (w/v) was sterilised by Gamma radiation (IBL-637 
CIS-BioINternational gamma irradiator, France) with 10 Gy at the rate of 1 Gy/min. 0.5 
mL of MDCKII cells, at a concentration of 8 × 10
6
 cells/ mL were suspended each with 
1 mL of 8 % w/v sodium alginate solution, resulting in a 6 % w/v sodium alginate 
solution with a cell concentration of 2.67 × 10
6
 cells/mL respectively. Similarly, 0.4 % 
(w/v) collagen solution was prepared containing 8 % (w/v) sodium alginate and 
sterilised by Gamma radiation with 10 Gy at the rate of 1 Gy/min. 0.5 mL of MDCKII 
cells with a concentration of 8 × 10
6
 cells/mL were separately added, resulting in a 0.26 
% (w/v) collagen and 6 % (w/v) sodium alginate solution at a cell concentration of 2.67 
× 10
6
 cells/mL. Stainless steel metal bars with a range of diameters were chosen as the 
mould for tubular structure fabrication due to their suitable wettability. . The metal bars 
were first kept in ethanol overnight to make them sterile. As shown in Figure 6.4, the 
mould was first dipped into a 6% (w/v) sodium alginate solution containing cells or 
dipped into collagen- alginate solution containing cells for about 3 seconds and then 
removed immediately. A thin layer of the cell-laden hydrogel was left coated on the 
surface of the metal bar. The coated surface of the metal bar was then dipped into the 
filtered cross-linking reagents (100 mM CaCl2 or 55mM BaCl2) for 2 minutes to cross-
link the sodium alginate. The cross-linked cell-laden hydrogel was then gently pulled 
out by tweezers from one end of the metal bar mould, leaving a hollow tubular structure 
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of cross-linked cell-laden hydrogel. Cell-laden tubular hydrogel structures were 
fabricated using a metal bar with a 1.2 mm diameter. 
 
Figure 6.4 __  Schematic drawing of the alginate hydrogel tubular structure fabrication process, (a) a 
metal bar mould dipped in 6% (w/v) sodium alginate to coat the surface with a thin layer of cell-laden 
alginate hydrogel, followed by (b) the exposure to 55mM BaCl2 or 100mM CaCl2 to fully cross-link the 
sodium alginate layer for 2 minutes and (c) the cross-linked alginate layer is be pulled out from the 
mould as a hollow tube. (d) An optical image of a fabricated cell-laden alginate hydrogel tub. Scale bar: 
500 µm. 
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6.6   MDCK cell viability within the fabricated tubular structures  
Fabricated cell-laden tubular structures under four different conditions were cultured for 
5 days and viability of the cells was examined every day.  
 
F
ig
u
re
 6
.5
 _
_
 M
D
C
K
II
 c
el
l 
vi
a
b
il
it
y 
w
it
h
in
 t
h
e 
tu
b
u
la
r 
st
ru
ct
u
re
s 
fa
b
ri
ca
te
d
 w
it
h
 t
h
e 
d
ip
-c
o
a
ti
n
g
 a
p
p
ro
a
ch
 u
n
d
er
 4
 d
if
fe
re
n
t 
co
n
d
it
io
n
s 
fr
o
m
 d
a
y 
0
 
to
 d
a
y 
5
 
 
  
 129   
 
 
Figure 6.6 
__ 
MDCKII cells cultured throughout 5 days within alginate hydrogel tube walls cross-linked 
by 100 mM CaCl2 or 55 mM BaCl2.Green stain indicates live cells and red stain indicates dead cells. 
Scale bar: 100 µm. 
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Figure 6.7 
__
 MDCKII cells cultured throughout 5 days within alginate-collagen hydrogel tube walls 
cross-linked by 100 mM CaCl2 or 55 mM BaCl2. Green stain indicates live cells and red stain indicates 
dead cells Scale bar: 100 µm. 
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Figure 6.8 
__ 
MDCKII cell culture throughout 5 days on a 6 well plate culture dish. Green stain indicates 
live cells and red stain indicates dead cells Scale bar: 100 µm 
 
The viability data were analysed using Image J, which suggested the cell survival rate 
within the tubular structures is generally above 80% for all four different fabrication 
conditions after the fabrication process. By comparing it with normal MDCKII cell 
culture, it appeared that the fabrication process is very gentle on cells and can sustain a 
high cell viability after fabrication. After 5 days of culture, MDCKII cells maintained 
cell viability of over 75% based on the four different fabrication conditions. Although 
the cell viability was lower than for the bioprinting approach in chapter 4, the viability 
relative to the control was high: above 90% for all days at all four different conditions.  
 
6.7   Fabrication of 3D hydrogel tubes with mouse dermal embryonic fibroblast, 
viability assay and imaging 
Sodium alginate at 8% (w/v) and collagen type 1 from rat tail were used as scaffold 
biomaterials for this 3D biofabrication process. 100 mM CaCl2 and 55 mM BaCl2 sterile 
solutions prepared in de-ionised water were used as the cross-linking reagents. Sodium 
alginate 8% (w/v) was sterilised by Gamma radiation with 10 Gy at the rate of 1 
Gy/min. 0.5 mL of cells, at concentration of 8 × 10
6
 cells/ mL were suspended each 
with 1 mL of 8 % (w/v) sodium alginate solution, resulting in a 6 % (v/w) sodium 
alginate solution with cell concentration of 2.67 × 10
6 
cells/mL. Similarly, 0.4% (w/v) 
collagen solution was prepared containing 8% (w/v) sodium alginate and sterilised by 
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Gamma radiation with 10 Gy at the rate of 1 Gy/min. 0.5 mL of mouse dermal 
embryonic fibroblast cells with concentration of 8 × 10
6 
cells/mL were separately 
added, resulting in a 0.26 % w/v collagen and 6 % w/v sodium alginate solution at a cell 
concentration of 2.67 × 10
6
 cells/mL. 1.2 mm stainless steel metal bars were used for 
the fabrication process. Precisely same fabrication process was followed to produce the 
cell-laden tubular structures. The cell-laden tubular structures containing mouse 
embryonic dermal fibroblasts were cultured for 6 days. A LIVE/DEAD® Cell Vitality 
Assay Kit (L34951, Life Technologies) was used according to the manufacturer’s 
protocol. The medium was briefly replaced with fresh medium containing 500 nM c12-
resazurin and 10 nM SYTOX Green before incubating at 37 °C, 5 % CO2 for 15 
minutes. The viability was assessed on day 1, 3, and 6. Confocal images of mouse 
embryonic dermal fibroblast cells were taken on a Nikon A1R FLIM confocal 
microscope. Z-Stacks (range of 176 µM, 5 µM steps) of each sample were captured 
using a Nikon A1R FLIM confocal microscope.   Images were analysed using Imaris 
software to investigate the viability of the cells encapsulated within the tube walls 
fabricated by 1.2 mm mould over day 1, day 3 and day 6 of culture. 
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6.8   Cell viability in alginate and collagen-alginate hydrogel tubular structures  
Tubular structures containing mouse dermal fibroblast cells were fabricated using the 
dip coating method by cell-laden alginate hydrogel cross-linked with 100 mM CaCl2 or 
55 mM BaCl2 solution as well as cell-laden Alginate-Collagen hydrogel mixture cross-
linked with 100 mM CaCl2 or 55 mM BaCl2 solution. Cell viability was monitored 
through 6 days of culture for each condition. The results suggested that the cells within 
alginate hydrogel tubes cross-linked with 55 mM BaCl2 had the highest viability of 84 ± 
2.4 % followed by collagen-alginate crosslinked by 55 mM BaCl2 showing cell viability 
of 81 ± 7.4 %. Cell viability in alginate hydrogel cross-linked by CaCl2 was 78 ± 3.1 % 
and alginate-collagen crosslinked by CaCl2 was 72 ± 4.4% as shown in Figure 6.10. The 
results showed a good viability after 6 days of culture within the tubular structures for 
all conditions. However, the slight decrease in viability in collagen-alginate mixture 
cross-linked by 100 mM CaCl2 and 55 mM BaCl2 could be due to the lower PH level of 
the collagen, which created a harsher environment for the cells to survive in. By 
neutralising the collagen the cell viability might have been enhanced and better cell 
viability could be recorded. The ability to incorporate other biomaterials with alginate to 
fabricate tubular structures potentially allows for a better extracellular matrix to be 
created or an even harsher environment could be used for the cells depending upon the 
desired applications.  
 
Figure 6.10 
__ 
Viability of the mouse embryonic dermal fibroblast cells within the fabricated tube walls 
over 6 days of culture in two different bio-inks cross-linked by 100 mM CaCl2 and 55 mM BaCl2 for 2 
minutes. 
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6.9   3D cell growth in alginate and collagen-alginate hydrogel tubular structures  
Confocal images of the mouse dermal fibroblast cells were taken for the four different 
conditions of fabrication at day 1, day 3 and day 6 as shown in Figure 6.9. Three 
random 300 µm × 300 µm × 50 µm areas within each tubular structure were selected to 
evaluate the cell number using Imaris software. The results shown in Figure 6.9 indicate 
that for all four conditions the cells had grown and proliferated in parts of the gel, which 
started the basis of cell to cell interaction and the formation of small clusters within the 
fabricated tube walls. The results showed that the fabricated gel had good permeability 
and porosity, allowing nutrients and oxygen to penetrate into the gel as well as allowing 
waste to be extracted from the gel. These optimum conditions created an extracellular 
matrix suitable for cell growth while supporting cell to cell interaction in some parts of 
the gel. Figure 6.11 summarises the cell density within the tubular structures fabricated 
in four different conditions throughout 6 days in culture. The cell density was 
considerably higher in alginate cross-linked with BaCl2 and cell viability results also 
indicated the highest viability was achieved in alginate cross-linked with BaCl2 over 6 
days of culture. 
 
Figure 6.11
__ 
Fibroblast cell density within the tubular structures fabricated by four different conditions 
at day 1, day 3 and day 6 
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6.10  Fabrication of 3D hydrogel tubes with tHEk cells and inducing tHEk cells 
with tetracycline and imaging 
Sodium alginate 8% (w/v) was sterilised by Gamma radiation with 10 Gy at the rate of 
1 Gy/min. 0.5 mL of human embryonic kidney 293 cells containing a tetracycline 
responsive red fluorescence protein (tHEK), at a concentration of 8 × 10
6
 cells/ mL was 
suspended with 1 mL of 8% (w/v) sodium alginate solution, resulting in a 6 % v/w 
sodium alginate solution with a cell concentration of 2.67 × 10
6 
cells/ mL. Similarly, 
0.4 % (w/v) collagen solution was prepared containing 8% (w/v) sodium alginate and 
was sterilised by Gamma radiation with 10 Gy at the rate of 1 Gy/min. 0.5 mL of tHEK 
cells with a concentration of 8 × 10
6 
cells/mL were separately added, resulting in a 
0.26% (w/v) collagen and 6% (w/v) sodium alginate solution at a cell concentration of 
2.67 × 10
6
 cells/mL. Tubular structures containing tHEK cells within the tube walls 
were fabricated using 1.2 mm rods as per the fabrication protocol and incubated for 24 
hrs. The medium was then replaced with fresh medium containing tetracycline at a 
concentration of 1 µg/mL. The structures were then incubated for a further 48 hrs. 
Images of the induced tHEK cells were captured after 72 hours using a Zeiss Axiovert 
Immunofluorescence microscope. 
 
6.11   Responsiveness of cells to small molecules  
To validate whether the walls of the tube allow cells to access small signalling 
molecules and whether they show normal gene expression responses to these, a tHEK 
cell line that activates expression of Red Fluorescent Protein (RFP) in response to 
tetracycline was used [1-3]. The tHEK cells were cultured for 24 hrs within the 
fabricated tube walls, again made using the four methods of tube manufacture (with and 
without collagen, and using either CaCl2 or BaCl2 to cross-link). The cells were then 
cultured for a further 48 hrs in the presence or absence of tetracycline. Cells cultured 
with no tetracycline could be detected but showed no red fluorescence (Figure 6.12a, c, 
e, g and i). Cells exposed to tetracycline showed a robust induction of RFP expression 
in all four conditions (Figure 6.12b, d, f, h and j). 
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Figure 6.12 
__
 Responsiveness of cells in the wall to small signalling molecules.  (a,c,e and g) show tHEK 
cells cultured in tubes made from, and cross-linked by, the reagents indicated, but not exposed to 
tetracycline. (b,d,f and h)_show tHEK cells in tubes made the same way but then exposed to tetracycline 
for 72h. Red fluorescent protein is robustly induced.  (i) and (j) show low-magnification images of the 
tubes containing cells before and after induction with tetracycline . 
 
Alginate + Ca
+2 
Alginate + Ba
+2 
Collagen-Alginate + Ba
+2 
Collagen-Alginate + Ca
+2 
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6.12   Incorporation of gelatine to increase cell attachment of MDCKII cells  
Gelatine (gelatine from porcine skin, Sigma-Aldrich, Gillingham, UK) was introduced 
to further investigate whether this would improve the attachment of the cells to the 
biomaterial [4-9]. Alginate, gelatine and alginate-gelatine solutions were coated onto a 
12 well plate. The alginate used in this study was at a concentration of 6% (w/v) and 
was cross-linked with 55 mM of BaCl2 for 2 minutes. The gelatine coated onto the well 
plate had a concentration of 6% (w/v) and was kept for 30 minutes to solidify. The 
gelatine-alginate coated composition with a final gelatine concentration of 6% (w/v) 
was cross-linked with 55 mM BaCl2. The coated well plates were then sterilised by 
gamma radiation with 20 Gy at the rate of 2 Gy/min. 1 mL of MDCKII cells in medium 
with a cell concentration of 0.3 × 10
6
 cells/mL was added to each well plate and 
cultured for 2 days in the incubator at 37 °C. Images of MDCKII cells on the alginate, 
gelatine, and alginate-gelatine compositions were taken at day 1 and day 2 of culture.  
 
Figure 6.13 
__
 MDCKII cells cultured on alginate, gelatin and alginate-gelatin composition 2D sheets for 
two days. Scale bar: 100 µm. 
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As shown in Figure 6.13, MDCK cells cultured for two days on cross-linked alginate 
sheets did not show a suitable morphology on day 1 and day 2, as cells formed clusters 
on top of the cross-linked alginate sheets. On the other hand, cells did form a suitable 
morphology on solidified gelatine sheets at day 1 and kept the same morphology at day 
2. Cells on cross-linked alginate-gelatine sheets showed better morphology compared to 
the alginate sheets, but not better than the gelatine sheets at day 1. At day 2 of culture, 
cells showed better morphology on alginate-gelatine compared to day 1.  
 
6.13   Incorporation of gelatine to enhance cell attachment of mouse dermal 
embryonic fibroblast 
To confirm the previous morphology experiments on MDCKII cells, mouse dermal 
embryonic fibroblast cells were tested and similarly added on alginate, alginate-gelatine 
and gelatine 2D sheets at 1 mL with a cell concentration of 300,000 cells/mL. Cells 
were cultured for two days at 37 °C in the incubator and were imaged on day 1 and day 
2.   
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Figure 6.14 
__
 Mouse dermal embryonic fibroblast cells cultured on alginate, gelatine and alginate-
gelatine composition 2D sheets for two days.  
 
Similar to MDCKII cells, mouse dermal embryonic fibroblast cells showed the better 
morphology at day 1 and day 2 when cultured on gelatine. Cells did not form a suitable 
morphology on cross-linked alginate sheets at day 1 and 2, and cells showed a much 
better morphology on cross-linked alginate-gelatine sheets compared to cross-linked 
alginate sheets. The results indicated the tubular fabrication method is potentially 
capable of keeping the cells alive within the tubular structures. By fine tuning the 
biomaterial, other cell types could potentially form a monolayer on either the inner or 
the outer surface of the tubular structures.  
 
6.14   U87-MG and mouse fibroblast cells seeding on alginate-gelatine tubular 
structures  
To further investigate the attachment of cells from 2D to 3D, alginate–gelatine tubular 
structures were fabricated. 6% (w/v) gelatine solution was prepared in de-ionised water 
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at 37 °C and sodium alginate powder was added to the gelatine solution. This was 
mixed, resulting in a final concentration of 6% (w/v) gelatine w/v and 6% (w/v) sodium 
alginate. A metal bar with a 4 mm diameter was used to fabricate tubular structures 
using the dip-coating approach at 37 °C. Tubular structures were cross-linked in 55 mM 
BaCl2 for 2 minutes. To sterilise the tubular structures, they were kept in ethanol 
overnight.  U87-MG cells and mouse fibroblast cells introduced to the tubular structures 
at a concentration of 0.3 × 10
6
 cells/mL and were cultured in the incubator at 37 °C and 
5% CO2 for 6 days. Images of the U87-MG cells and mouse fibroblast cells seeded 
inside the tubular structures were taken on day 0, 1, 4 and 6. 
 
Figure 6.15 
__
 U87-MG cells seeded inside alginate-gelatine tubular structures and cultured for 6 days.  
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Figure 6.16 
__
 Mouse fibroblast cells seeded inside alginate-gelatine tubular structures and cultured for 6 
days.  
 
U87-MG cells, as shown in Figure 6.15, were attached to the inside of the alginate-
gelatine tubular structures at day 0, but the cells did not have a good morphology. At 
day 1 the cells had started to grow and form colonies on the surface of the tubular 
structures, and the clusters grew larger at day 4 but the morphology was still poor. 
However, at day 6 cells started to form normal morphology inside the tubular structures 
and cell clusters were not visible anymore.  
Seeded fibroblast cells inside the alginate–gelatine tubular structures as shown in Figure 
6.16 formed small cell clusters at day 0 and day 1 and normal morphology was not 
visible. At day 4 these small clusters had started to interact with each other to form a 
better morphology on the surface of the tubular structures. At day 6, there were no more 
clusters visible inside the tubular structures and normal cell morphology is noticeable. 
6.15  Addition of gelatine nanofibres and micro-carriers to enhance cell 
attachment 
To increase cell attachment within the tubular structures, gelatine nanofibres and 
microcarriers were introduced. 1 mL of gamma-sterilised 8% (w/v) sodium alginate was 
  
 143   
 
mixed with 0.1 g of sieved gelatine nanofibres (beads smaller than 100 µm) fabricated 
in accordance with the protocol [10], 0.1 g of non-sieved gelatine numbers (beads 
greater than 100 µm), 0.1 g of microcarriers and 0.05 g of microcarriers with 0.5 g of 
non-sieved microcarriers. The compositions were mixed with 0.5 mL of U87-MG cells 
in a culture medium with a concentration of 10 × 10
6 
cells/mL, resulting in an 
approximately 6% (w/v) alginate with 10% (w/v) of the support matrix having a cell 
concentration of 3.67  × 10
6 
cells/mL. Tubular structures were fabricated with the dip-
coating approach with a 1.2 mm mould bar cross-linked by 55 mM BaCl2 and cultured 
for 2 days in the incubator at 37° C and 5.0% CO2. 
 
6.15.1   Gelatine nanofibre fabrication to enhance cell attachment  
10 g of gelatine powder (gelatine from porcine skin, product code 10011968154, Sigma 
Aldrich UK) was mixed with 20 mL of de-ionised water. 40 mL of acetic acid was 
added to the water-gelatine solution and was gently stirred for 5 minutes.  32 mL of 
ethyl acetate was added to the solution and stirred gently for 5 another minutes. The 
final solution was then incubated for 12 hrs at 37 °C. 
Once incubated for 12 hours 3 mL of the water-acid based gelatine solution was loaded 
into a 5 ml syringe and electro spun for 24 hrs at 0.06 ml/hr by 12.5 kV/8 cm with a 500 
µm tip.  
 
Figure 6.17 
__ 
(a) water-acid based gelatine solution after 4 hrs and (b) after 24 hrs of electrospinning   
  
The fabricated fibrenanofibres then were removed from the top of aluminium foil and 
ground using an electric grinder and sieved with 100 µm sieve in order to produce small 
beads of fibrenanofibres. Fabricated nanofibres had diameters ranging from 50 nm to 
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250 nm. Once the nanofibres were ground, a 100 µm sieve was used to separate the 
beads that are smaller than 100 µm. 
 
Figure 6.18 
__ 
(a) water-acid based gelatine solution after 4 hrs and (b) after 24 hrs of electrospinning   
 
Samples were taken from electrospun gelatine nanofibres, transferred to the gold sputter 
coating instrument and vacuumed before SEM examination. Vacuumed sputter coating 
was performed at 2.5 kV and 20 mA for 45 seconds, resulting in gold layers on the 
samples a few nanometre thick. Sputter coated samples then were taken to SEM for 
imaging. Images were taken at 5 kV with magnifications of 3000, 5000, 20000 and 
50000 as shown in Figure 6.19. 
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Figure 6.19
__
 SEM images of gelatine nanofibres taken at 5 KV with 3000, 5000, 20000 and 50000 
magnifications.  
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Figure 6.20 – U87-MG cells encapsulated within tubular structures fabricated using the dip-coating 
approach. The bio-ink compositions were; alginate, alginate-microcarrier, alginate-microcarrier-
nanofibre, alginate-nanofibre (beads smaller than 100 µm) and alginate-nanofibre (beads greater than 
100 µm). 
 
The addition of gelatine nanofibres to alginate resulted in a very low cell viability. This 
could be due to the possible existence of acid residues within the gelatine nanofibres, 
which is harmful to cells. On the other hand, the addition of microcarriers to alginate 
improved the cell attachment compared to the alginate only and alginate-gelatine 
nanofibre-microcarrier compositions.  
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6.17 Conclusions  
In this chapter biological studies were carried out based on the dip-coating approach. 
This approach could incorporate other bio-materials within the alginate hydrogel to help 
cell biologists to bypass the lengthy, complicated and expensive fabrication approaches 
and integrate the dip-coating method to fabricate 3D tubular structures with living cells 
in their preferred extracellular matrix. The fabrication method was gentle on live cells 
while maintaining high cell viability over 6 days within the tubular structures. This 
provided a platform for cells to freely interact with small molecules such as the 
tetracycline used as a demonstration here. By introducing other biomaterials cooperated 
with alginate it was possible to enhance the cell attachment within the tubular structures 
as well as the capability to form cell monolayers on the inner or outer surface of the 
tubular structures. 
This method shows promising potential for fabricating tubular structures that are better 
models of anatomy than 2D cultures. These may be suitable for a range of tubular 
tissues including embryonic kidney, lymph vessels, blood vessels, trachea, and intestine. 
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Chapter 7 -
  
Conclusions and future work 
In this thesis, two different approaches were developed for the 3D biofabrication of 
complex cell-laden hydrogel structures with sodium alginate as the main hydrogel. The 
first approach involved a novel extrusion-based bioprinting approach where cell-laden 
alginate hydrogel structures were bioprinted through a three step alginate hydrogel 
cross-linking process (primary, secondary and tertiary). This was done through use of 
CaCl2 and BaCl2 providing a novel 3D bioprinting platform to deliver a sufficiently 
viscous alginate bio-ink for printability whilst minimising the shear stress applied to the 
cells during the printing process. The three-step cross-linking process not only led to 
robust and stable structures of the cross-linked alginate but also exhibited suitable 
controllability over its degradation time. This allowed cells to stay viable, proliferate 
and grow to form their own extracellular matrix within the hydrogel after 9 days. Co-
printing of two different alginate hydrogels was also demonstrated, indicating the ability 
to co-print two different cell types. The summary of this work is shown in figure 7.1.    
The other method for the biofabrication of complex cell-laden alginate hydrogel was the 
micro dip-coating approach. This created a very simple, rapid and straight-forward 
platform with the ability to incorporate other biomaterials to create a suitable 
environment for desired applications. Tubular structures were fabricated by this method 
and it was possible to control the thickness of tubular structures by adjusting the 
alginate hydrogel concentration. This method is capable of producing ultrafine tube 
diameters down to 100 µm, as well as multi-layered alginate hydrogel tubular 
structures. Different cell types were used to create tubular structures and viability results 
showed this approach is gentle on cells, allowing them to proliferate, grow and function. 
Swapping the solid metal bar mould for a bio-compatible 3D printed dissolvable mould 
allowed real size complex hollow organ structures such as a stomach and branched 
structures to be rapidly fabricated. The summary of this work is shown in figure 7.2. 
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Figure 7.1 
__
  The completed milestones in order to bioprint live cells into a complex 3D structures while 
keeping the cell viability high over 10 days. 
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Figure 7.2 
__
 The completed milestones in order to validate a new rapid biofabrication approach to 
produce tubular and complex structures through dip-coating by keeping the cells viable and maintaining 
their normal function. 
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Future work on bioprinting 
Despite being capable of producing complex cell-laden hydrogels with both methods, 
there are several improvements needed to allow both methods to achieve their full 
capability to meet a variety of applications in tissue engineering. The recommendations 
for future improvements are as follows. 
 The printing XYZ resolution needs to be improved. Structures with wall 
thicknesses smaller than 100 µm or even single cell resolution need to be printed 
in order to get closer to physiological conditions. To achieve this goal a smaller 
printing tip must be used; however the current bioprinter’s X-Y-Z resolution is 
limited to 100 µm and therefore new step/servo motors are needed to replace the 
current servo motors. By decreasing the tip diameter, cells will be under a higher 
shear stress. Cell studies therefore need to be carried out to evaluate the 
significance of this change after bioprinting.  
 
 Different types of alginate hydrogel with different molecular weights or even a 
different composition of alginate with other biomaterials such as gelatin, 
collagen and chitosan should be tested and printed in order to enhance the cell 
attachment to the gel and encourage faster cell proliferation within the gel. There 
is a wide range of alginate hydrogels available, with different viscosities and 
molecular weights. However, partial cross-linking studies of these hydrogels 
needs to be performed and printing configurations need to be fine-tuned and 
adjusted for each hydrogel. 
 
 Despite the ability to co-print two types of hydrogels, cell studies were not 
carried in this instance.  Therefore different cell types need to be printed and cell 
to cell interaction between the two cell types need to be investigated. The idea 
can simply be performed by printing two lines merging together each containing 
a different cell type. The addition of other print heads to make printing more 
than two cell types possible. The addition of different print heads such as a valve 
head could be helpful due to some cells being very sensitive to the bio-extrusion 
process, particularly stem cells.  
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Future work on rapid biofabrication via dip-coating  
 
 The fabrication method is a manual process and automating the process would 
be helpful to the fabrication procedure to generate more precise tubular 
structures with reproducible results. Manual fabrication will encounter many 
human errors; automating the dip-coating process can minimise fabrication 
errors such as tube wall thickness variations. For example, by using a rotary 
system the wall thickness distribution can be even throughout the entire tubular 
structure.  
 
 The bio-ink used for fabrication was limited to one type of alginate hydrogel. 
The use of other alginate hydrogels with different molecular weight could 
perhaps produce better results and lower concentrations of cross-linking reagents 
could be needed. Due to the different viscosities of these hydrogels the tube wall 
thickness could differ from the presented data and new studies must be carried 
out in this regard. 
 
 Gelatine, collagen and gelatine nanofibres were used with alginate to investigate 
the cell behaviour in these compositions.  Other biomaterials such a chitosan, 
different types of collagens and gelatines could be tested with alginate to 
produce better data and allow for comparison between compositions.  
 
 Cell studies need to be carried out on the multi-layered tubular structure 
fabrication to understand cell to cell interactions between the layers, as this 
approach has the potential to generate or mimic blood vessels. For example, part 
of a blood vessel consists of fibroblast and smooth muscle cells; in theory these 
cells can be placed into two different layers by the dip-coating approach. The 
layers consisting of the smooth muscle cells can use alginate-gelatine hydrogel 
and endothelial cells can then be seeded in the inner wall to form monolayers on 
the surface. Also, a more systematic study into 3D complex fabrication protocol 
and cell studies is highly recommended. This may include the use of different 
hydrogels, mechanical testing and biocompatibility.  
 
